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“Intellect is in itself a mode of 
exaggeration, and destroys the harmony of 
any face.” 
 
Oscar Wilde 
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 ABBREVIATIONS 
 
 
 
2-DE Two-dimensional gel electrophoresis  
ANOVA One factor analysis of variance  
ATP Adenosine-5'-triphosphate 
BDNF Brain derived neurotrophic factor 
CgCtx Cingulate cortex 
CHESS Chemical shift selective  
CP Caudate putamen 
Cre Creatine 
CRH Corticotrophin releasing hormone 
CS Conditioned stimulus 
DAT Dopamine transporter 
D1R Dopamine 1 receptor 
D2R Dopamine 2 receptor 
ELISA Enzyme-linked immunosorbent assay 
FWHM Full-with-at-half-maximum  
FST Forced swim test 
1H-MRS Proton magnetic resonance spectroscopy  
HPA Hypothalamus-pituitary-adrenal 
HR High stress reactive 
i.p Intraperitoneally  
IR Intermediate stress reactive 
ITI Inter-trial interval 
KWH-test Kruskall-Wallis H-test 
Li Latent inhibition 
LiCl Lithium chloride 
LTP Long term potentiation 
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LR Low stress reactive 
MALDI Matrix-assisted laser desorption/ionization 
MEMRI Manganese-enhanced magnetic resonance 
imaging  
MD Major Depression 
MnCl2 Manganse Chloride 
MR Magnetic resonance  
MRI Magnetic resonance imaging 
MWU-test Mann-Whitney U-test 
MS Mass spectrometry 
N Number of animals 
NAc Nucleus accumbens 
NAA N-acetylaspartate  
NAAG N-acetyl-aspartylglutamate  
NaCl Sodium chloride 
No-PE Non Pre-exposed 
NOR Novel object recognition 
PFC Prefrontal cortex 
PE Pre-exposed 
pI/MW Isoelectric point/molecular weight 
ppm Parts per million 
RARE Relaxation enhanced  
ROI Region of interest 
RIA  Radioimmunoassay 
SEM Standard error of the mean 
S/N Signal to noise ratio 
SNP Single nucleotide polymorphism 
SR Stress reactivity 
SRT Stress reactivity test 
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SVZ Subventricular zone 
SZ  Schizophrenia 
T Total acrylamide-bisacrylamide monomer 
concentration 
T1w T1-weighted  
T2w T2-weighted 
TOF Time-of-flight mass spectrometer 
US Unconditioned stimulus 
VTA Ventral tegmental area 
W-test Wilcoxon-test 
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SUMMARY 
 
The hypothalamus-pituitary-adrenal (HPA) axis has repeatedly been found to be dysregulated in 
patients suffering from major depression (MD), as well as in patients suffering from 
schizophrenia (SZ). In this body of work, the relationship between stress reactivity and cognitive 
deficits, relevant to MD and SZ, has been investigated, using a mouse model of affective 
disorders, the “stress reactivity” (SR) mouse model. The SR mouse model consists of three lines 
of mice, selectively bred for high (HR), intermediate (IR), and low (LR) stress reactivity, 
respectively.  
These three mouse lines were subjected to tests of prefrontal cortex- (PFC) and 
hippocampus-dependent memory, as well as a test of selective attention associated with psychotic 
behavior. In addition, mechanisms whereby increased stress reactivity may cause cognitive 
deficits were studied, using several different methods, including; in-situ hybridization, proton 
magnetic resonance spectroscopy (H+-MRS), manganese enhance magnetic resonance imaging 
(MEMRI) and proteomics.  
The results revealed that HR mice have deficits in PFC- and hippocampus-dependent 
tasks, in similarity to patients suffering from MD and SZ. In addition, latent inhibition, a measure 
of selective attention associated with psychosis, was found to be disrupted in HR mice. 
Furthermore, H+-MRS revealed that HR mice have decreased levels of N-acetylaspartate, a 
marker of neuronal integrity, in the hippocampus and PFC. The activity of the hippocampal 
neurons was additionally reduced as measured by MEMRI. These findings also coincide well 
with finding in patients suffering from MD and SZ. 
In contrast, neither the volume of the hippocampus, nor the volume of the PFC was 
reduced in HR mice in comparison to the other lines. This implies that the reasons for a less well 
functioning hippocampus and PFC in the HR mice is not due to a global shrinkage of the 
structures, but rather due to more subtle changes on a cellular level. We have found that these 
changes include decreased BDNF levels in the hippocampus and alterations of the PFC 
dopaminergic (DA) system, as well as alterations in proteins involved in energy metabolism in 
the hippocampus. Interestingly, similar changes have also been reported in patients suffering 
from SZ and MD, in relation to specific cognitive deficits.  
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Taken together, the findings presented here provide construct and face validity for the HR 
mouse line as a model for the cognitive deficits in SZ and MD. These experiments are also the 
first to show that a genetic predisposition for an increased in stress reactivity, without repeatedly 
subjecting the animals to a stressor or synthetic glucocorticoids, is sufficient to induce 
hippocampal and PFC dysfunction. The SR mouse model could thus be used in future studies to 
further our understanding of the etiology of cognitive deficits in MD and SZ and be a promising 
tool in the search for new treatment strategies for these disorders.  
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AIMS OF THE THESIS 
 
The aim of this thesis was to characterize the three lines of mice selectively bred for extremes in 
stress reactivity with regard to their cognitive phenotype. We furthermore aimed to investigate 
the morphology and functionality of brain areas relevant to cognition. Ultimately the goal was to 
gain insight into the role of an increased hypothalamus-pituitary-adrenal axis reactivity in the 
etiology of symptoms of major depression and schizophrenia, with an emphasis on cognitive 
deficits frequently observed in patients suffering from these disorders.  
 
 
SPECIFIC AIMS 
 To investigate hippocampus-dependent memory, prefrontal cortex-dependent memory and 
measures of psychotic-like behavior in the stress reactivity mouse model 
 To investigate underlying mechanisms of cognitive deficits in highly stress reactive mice 
 To find phenotypic similarities between the stress reactivity mouse lines and patients 
suffering from major depression or schizophrenia 
 To elucidate the underlying biological mechanisms of these phenotypic similarities 
 To use the stress reactivity mouse model to investigate new targets to treat major 
depression and schizophrenia 
 To use the stress reactivity mouse model to further our understanding of the etiology of 
major depression and schizophrenia 
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INTRODUCTION 
 
MAJOR DEPRESSION 
Major depression (MD) is a highly debilitating disorder, with a lifetime prevalence estimated to 
between 13 and 17 percent in Europe and the United States of America (Carta et al., 1995). It is a 
life threatening disorder, as MD is the most important risk factor for suicide, with two thirds of 
suicides being committed by patients suffering from MD (Sartorius, 2001). MD is also one of the 
leading causes of disability worldwide and causes substantial socioeconomic losses (Wong and 
Licinio, 2001). The US economy alone is estimated to loose 43 billion dollars per year due to MD 
(Greenberg et al., 1993). One of the reasons for these large economical losses is that for a large 
portion of the patients we are still lacking successful treatment options that allow the patients to 
resume a fully functioning life.  
 
 
Symptoms of Major Depression 
MD is a very heterogeneous disorder, which may partly explain why it is such a difficult disorder 
to treat. MD is characterized in the diagnostic and statistical manual of mental disorders (DSM) 
(APA, 2000) by a certain duration and number of symptoms, that cause impairment and 
dysfunction, distinguishing the disorder from normal sadness or grief. These symptoms include; 
depressed mood, feelings of worthlessness, diminished interest or pleasure in activities, large 
change in appetite or weight gain, psychomotor agitation or slowness of movement, fatigue and 
recurrent thoughts of death (APA, 2000).  
Apart from these core symptoms of MD, patients also suffer from cognitive deficits. 
These cognitive deficits are mainly in the realm of executive functioning (Austin et al., 2001; 
Porter et al., 2003; Reppermund et al., 2007) and verbal memory deficits (Reppermund et al., 
2007). Interestingly, the cognitive symptoms have been reported to precede the onset of MD, 
(Airaksinen et al., 2007) and often remain when the patients’ other symptoms have successfully 
been treated (Reppermund et al., 2007). This raises the question whether the symptoms are a 
more integral part of the disease’s development, rather than a byproduct of MD.  
In addition to the affective and cognitive symptoms of MD, there are also physiological 
alterations that are characteristic of the disease. The most prominent and robust finding is an 
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increased hypothalamus-pituitary-adrenal (HPA) axis activity (Holsboer, 2000; Ising et al., 2005). 
Many studies have shown that excessive exposure to glucocorticoids has a detrimental effect on 
neurons (Sapolsky et al., 1990; Watanabe et al., 1992; Sousa et al., 1999; McKittrick et al., 2000; 
Lyons et al., 2007). Brain areas involved in cognition, such as the hippocampus and PFC have 
abundant glucocorticoid receptors. Thus, an excess exposure to glucocorticoids has been 
implicated in the cognitive deficits in depression. The exact mechanism by which the damage 
occurs to these areas is however still not precisely known.  
 
 
Subtypes of Major Depression 
Due to the heterogeneity of MD, certain subtypes of depression have been proposed. DSM-IV 
lists two distinct clinical depressive syndromes; melancholic and atypical depression. These two 
types of depression are the antithesis of one another in many aspects. The term atypical 
depression stems from a group of depressed patients who did not respond to typical 
antidepressants, however, they did respond to monoamine oxidase inhibitors (MAOIs) (Parker et 
al., 2002). These patients were less likely to report early morning wakening or worsened mood in 
the morning and were also less likely to have a pattern of clinical features consistent with “the 
more classical endogenous depression” (Parker et al., 2002). The DSM-IV criteria for atypical 
features also include hypersomnia and hyperphagia. Atypical depression has furthermore been 
associated with being overweight and aggressive personality traits (Nierenberg et al., 1998; 
Hasler et al., 2004). Interestingly, it has also been reported that patients suffering from atypical 
depression more commonly have a hypoactive HPA axis rather than a hyperactive HPA axis as is 
most commonly associated with MD (Gold et al., 1995).  
Increased HPA axis activity on the other hand has more specifically been associated with 
melancholic depression (Gold and Chrousos, 2002). Melancholic depression in contrast to 
atypical depression features hyperarousal, decreased sleep, decreased food intake and decreased 
body mass (Gold et al., 2002). Psychotic MD (PMD) has also been more strongly associated with 
an increased HPA axis activity than non psychotic MD (NPMD) (Gomez et al., 2006). PMD also 
has other specific features that distinguish it from NPMD. Patients with psychotic features often 
have a higher depression score, more frequent psychomotor difficulties, increased feelings of 
guilt and are typically more difficult to treat (Keller et al., 2007). The course of the depressive 
episodes has also been found to be different in those who exhibit psychotic features. PMD 
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patients often have a longer duration of episodes (Coryell et al., 1987; Maj et al., 2007) and a 
greater likelihood of recurrent depression (Lykouras et al., 1986; Aronson et al., 1988). Cognitive 
deficits are also more prominent in PMD (Cornell et al., 1984; Austin et al., 1999; Basso and 
Bornstein, 1999) 
 
 
Treatment Options for Major Depression 
The most common first-line treatment for MD are selective serotonin reuptake inhibitors (SSRIs) 
(Koenig and Thase, 2009; Rakofsky et al., 2009). SSRIs are however not always successful in 
treating the symptoms of MD and also have a myriad of side-effects, such as sexual dysfunction, 
dry mouth and weight gain (Koenig and Thase, 2009). Due to the many side effects there is a 
high incidence of non-compliance in patients. In cases where SSRIs are ineffective, other types of 
drugs can be used including combined serotonin-norepinephrine reuptake inhibitors or tricyclic 
antidepressants (Shelton et al., ; Koenig and Thase, 2009; Rakofsky et al., 2009). Tricyclic 
antidepressants can however exasperate cardiac diseases, so they should be used with caution 
(Haanpaa et al.). PMD is most commonly treated with a combination of SSRIs and antipsychotics 
(Goodwin et al., 2009). Monoamine oxidase inhibitors (MAOIs) are in many cases more effective 
in treating atypical depression, but they have interactions with common foods, including cheese 
and certain types of meat (Fiedorowicz and Swartz, 2004). It is furthermore possible to commit 
suicide by over-dose of MAOIs, which is not ideal for the treatment of depression (Fiedorowicz 
and Swartz, 2004). Some patients do not respond well to any of the above mentioned treatment 
options, and furthermore, there is a delayed response to antidepressant treatment, which can be of 
crucial importance when dealing with suicidal patients. It is therefore apparent that the there is a 
need for better treatment strategies for treating MD.  
 
 
SCHIZOPHRENIA 
The lifetime risk of SZ is approximately one percent, with a predominant genetic influence 
(Sartorius et al., 1986; Cannon and Jones, 1996). Most patients continue to show some degree of 
incapacity and need to be medicated for the rest of their lives. The cost in loss of productivity as 
well astreatment costs for SZ are therefore substantial (Andreasen, 1995).  
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Symptoms of Schizophrenia 
The diagnosis of SZ is based upon the presences of certain so-called “positive symptoms”, that 
include delusions, hallucinations and thought disorder, as well as “negative symptoms”, such as 
avolition, alogia and affective flattening (Andreasen, 1995). According to the DSM-IV these 
symptoms must be present for a minimum of six months and may not be secondary to any other 
disorder, such as depression or substance abuse (APA, 2000). There are also physiological 
alterations characteristic of SZ, including ventricular enlargement and decreased cortical and 
hippocampal volume (Harrison, 1999). Interestingly, an increased HPA axis reactivity has also 
been reported in patients suffering from SZ (Muck-Seler et al., 2004; Ryan et al., 2004; Gallagher 
et al., 2007; Ritsner et al., 2007). 
 
 
Treatment Options for Schizophrenia 
The first generation of antipsychotics, the so-called “typical antipsychotics” are dopamine 2 
receptor (D2R) inhibitors (Snyder and Murphy, 2008). They are relatively effective in treating 
positive symptoms, however, they are known to cause extrapyramidal movement disorders 
(Snyder and Murphy, 2008). The second generation of antipsychotics, “atypical antipsychotics”, 
inhibit D2Rs as well as other receptors including 5-hydroxytryptamine 2A receptors (Snyder and 
Murphy, 2008). The atypical antipsychotics are less likely to cause extrapyramidal side effects, 
however they cause other side-effects, such as weight gain, prolactin and glucose elevation, and 
sedation (Snyder and Murphy, 2008). A striking 74 percent of patients discontinue the use of 
their medication within 18 months of treatment, due to these side effects or poor efficacy of the 
drugs (Lieberman et al., 2005), leading to the need for improved pharmacological treatment 
options for patients suffering from SZ.  
 
 
SIMILARITIES BETWEEN MAJOR DEPRESSION AND SCHIZOPHRENIA 
Cognitive deficits in MD are more predominant in patients suffering from melancholic depression 
or who have psychotic-like features (Cornell et al., 1984; Austin et al., 1999; Basso and 
Bornstein, 1999), which leads to a parallel to schizophrenia (SZ), a disorder characterized by 
psychotic episodes along with several well characterized cognitive deficits (APA, 2000). These 
deficits include prefrontal cortex (PFC) dependent tasks (Goto et al., ; Floresco et al., 2009) in 
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similarity to patients suffering from MD (Austin et al., 1999; Merriam et al., 1999), as well as 
deficits in sensorymotor gating (Braff et al., 1978; Perry et al., 2002; Martinez-Gras et al., 2009) 
and the ability to ignore irrelevant stimuli in paradigms such as latent inhibition (Baruch et al., 
1988; Guterman et al., 1996; Rascle et al., 2001; Schmidt-Hansen et al., 2009). Furthermore, 
patients suffering from melancholic or PMD and patients suffering from SZ have been reported to 
have an increased HPA axis reactivity (Holsboer, 2000; Muck-Seler et al., 2004; Ryan et al., 
2004; Ising et al., 2005; Gallagher et al., 2007; Ritsner et al., 2007). This provides a possible 
common underlying mechanism for the cognitive deficits in both disorders. In this body of work, 
we have therefore studied these cognitive symptoms as a phenotypic endpoint relevant to both SZ 
and MD.  
 
 
MODELING PSYCHIATRIC DISEASES IN MICE 
Psychiatric diseases are among the most difficult diseases to model due to the complex nature of 
the symptoms that are mainly in the realm of higher order cognitive processes. A good animal 
model of a disorder should provide face-, construct-, and predictive- validity (Anisman and 
Matheson, 2005). The face validity of a mouse model pertains to the similarity of the phenotype 
of the mouse model to the symptoms of the disease it is to model. Construct validity refers to the 
animal model of a disorder and the patients suffering from this disorder having a common 
underlying mechanism of these symptoms. Finally, predictive validity concerns the ability of 
known treatment strategies to reverse the symptoms in the mouse model in similarity to clinical 
observations.  
 There are several models used to test “depression-like” behavior in mice. The test we have 
used here, the forced swim test (FST), is the most common test of face- and predictive validity of 
mouse models of depression (Porsolt et al., 1977; Cryan and Holmes, 2005). In this test, the mice 
are placed in a cylinder of water for six minutes. At first, the animal will actively try to escape by 
struggling and swimming, but will eventually “give up” and adopt a more passive coping 
strategy, i.e. floating. An increased amount of time spent floating and a shorter latency to start 
floating is interpreted as increased “depression-like” behavior (Porsolt et al., 1977; Cryan and 
Holmes, 2005). Increased struggling behavior, on the other hand, indicates a more active coping 
strategy and hyperarousal (Porsolt et al., 1977; Cryan and Holmes, 2005).  
 
Introduction  19
 
 
 In modeling SZ, the main focus in providing face validity for a model has been on the 
cognitive deficits associated with psychotic behavior, as delusions and hallucinations are not 
possible to assess in mice. One test used to assess selective attention deficits associated with 
psychotic behavior, is latent inhibition (Li) (Lubow, 2005). Li is the phenomenon whereby the 
pre-exposure to the to-be conditioned stimulus, retards subsequent pairing of the unconditioned 
stimulus to the conditioned stimulus (Lubow, 1973) and has been associated specifically with 
psychotic episodes in SZ (Lubow et al., 2000).  
 
 
THE STRESS REACTIVITY MOUSE MODEL 
The stress reactivity (SR) mouse model was established to model on of the core neuroencdocrine 
symptoms of MD. This model consists of three lines of mice that are selectively bred for high 
(HR), intermediate (IR) or low (LR) stress reactivity. This was achieved by taking a founder 
population of CD-1 mice and testing their plasma corticosterone increase in response to a 15-min 
restraint stressor. Male and female mice with extremely high HPA axis reactivity were selected 
and mated to create the HR mouse line and mice with extremely low stress reactivity were mated 
in order to create the LR line. This procedure was then repeated for each generation. The third 
line, the IR line was selected according to an intermediate stress reactivity, representative of the 
average CD-1 mouse and serves as a control group with the same inbreeding status as the HR and 
LR mice.  
The stress reactivity mouse model has previously been established as a mouse model of 
MD (Touma et al., 2008; Touma et al., 2009). The highly stress reactive mice show robustly 
increased corticosterone levels in the plasma and hippocampus in response to a standardized 
stressor, in comparison to IR and LR mice (Touma et al., 2008; Heinzmann et al., under revision). 
In accordance with this, adrenocorticotropic hormone (ACTH) levels were also increased in 
response to a standardized stressor in HR mice. The HR mice also have an increased adrenal 
gland weight in comparison to IR and LR mice. Furthermore, the diurnal rhythm of 
glucocorticoid secretion of the three mouse lines has been investigated, using a non-invasive 
technique measuring corticosterone metabolites in fecal samples (Touma et al., 2008; Touma et 
al., 2009). This showed that the circadian rhythm of the HR mice was flattened with an increased 
nadir in comparison to the other two lines. The circadian peak of the corticosterone secretion, 
however, did not differ between the three lines. In similarity to patients suffering from MD, the 
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HR mice also have an increased response to the dexamethasone/ corticotropin releasing hormone 
(CRH) test. Interestingly, the CRH and arginine-vassopressin levels in the paraventricular nucleus 
of the HR mice did not differ between the three lines.  
In the FST, HR mice show increased struggling and decreased floating in comparison to 
IR and LR mice, indicative of increased arousal and a hyper-active coping style (Touma et al., 
2008; Knapman et al., 2009). The HR mice are thus similar to the melancholic and psychotic 
subtype of depression, whereas the LR mice are more similar to the atypical subtype of 
depression. The LR mice also show other similarities to patients suffering from atypical 
depression, such as increased body weight in the absence of increased food intake and increased 
social aggression (Touma et al., 2008). Furthermore, the sleep architecture of the HR mice is 
similar to patients suffering from MD with increased sleep fragmentation, increased rapid eye 
movement sleep and decreased slow wave activity (Touma et al., 2009). It should also be noted 
that the three lines do not differ in anxiety related behavior, as differences in anxiety would be a 
confounding factor in many of the behavioral tests presented here (Touma et al., 2008).  
 
 
AIMS AND SCOPE OF THE THESIS  
The studies presented here aimed to further characterize the stress reactivity mouse model with 
regard to its cognitive phenotype, in order to better understand the link between stress reactivity 
and cognitive deficits and to provide construct and face validity for the HR mouse line as a model 
MD and SZ. To this end, mice from the three breeding lines were subjected to a number of 
learning and memory paradigms. Firstly, we aimed to assess the hippocampus-dependent 
memory. This was achieved by using two tasks that take advantage of the mice innate preference 
for novelty, namely the novel object recognition (NOR) task and the Y-maze task. The first task, 
the NOR task is used to assess object memory which is believed to be dependent on the 
hippocampal formation and adjacent areas such as the perirhinal cortex (Dere et al., 2007). The 
second task, the Y-maze task, is a spatial learning task that lesion studies have revealed to be 
hippocampus-dependent (Sanderson et al., 2009) (see paper I). 
Assessing executive functioning in mice in a similar manner to the tests conducted 
clinically is not feasible. However, tests that employ the same brain areas as executive 
functioning tasks, namely the PFC have been designed for mice and other rodents. One of the 
most common of these is a reversal learning task in a water filled T-maze. This test was not 
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suitable to subject the SR mouse model to though; as the swimming-induced stress would cause 
an acute effect on memory that would severely confound our results. In order to assess PFC-
dependent tasks in the SR mouse model, we therefore designed a dry-land version of the T-maze 
reversal learning task involving a minimal amount of stress (see paper II). Reversal learning 
provides an analogue to the Wisconsin Card Sorting test, which is commonly used to assess 
medial PFC function in humans (Lie et al., 2006). Patients suffering from both SZ and MD have 
been found to have deficits in performing this task (Volz et al., 1997; Merriam et al., 1999; Rabin 
et al., 2009; Shirayama et al., 2009).  
As cognitive deficits are more commonly observed in patients exhibiting psychotic 
symptoms or suffering from melancholic depression (Cornell et al., 1984; Austin et al., 1999; 
Basso and Bornstein, 1999), it was also of importance to assess psychotic-like behavior in the SR 
mouse model. A paradigm that has been shown to assess selective attention deficits associated 
with psychotic symptoms in mice is Li (Baruch et al., 1988; Guterman et al., 1996; Rascle et al., 
2001; Schmidt-Hansen et al., 2009). Li is the phenomenon whereby the pre-exposure of a to-be 
conditioned stimulus (CS) retards the learning of the subsequent CS –unconditioned stimulus 
(US) pairing (Lubow, 1973). Li can be assessed in several ways. In order to test the SR mouse 
model, a conditioned taste aversion paradigm was chosen, where the CS was sucrose solution and 
the US was sickness, induced by a lithium chloride injection (see paper II). 
Once the cognitive phenotype of the SR mouse lines had been assessed, the underlying 
mechanisms of the differences in behavior between the three lines were investigated using a 
number of different methods. In the first instance, brain-derived neurotrophic factor (BDNF) was 
measured using an enzyme-linked immunosorbent assay (ELISA) (see paper I). BDNF has been 
shown to be involved in cognitive processes and is regulated by glucocorticoids, making it an 
interesting candidate to explain differences in the cognitive performance of the SR mouse lines. 
Furthermore, depressed patients have been reported to have reduced plasma BDNF levels, which 
are normalized in response to antidepressant treatment (Nibuya et al., 1996; Santarelli et al., 
2003; Lee et al., 2007; Huang et al., 2008; Monteleone et al., 2008). BDNF is therefore a 
promising target to investigate in the search for drug targets able to improve cognitive abilities in 
depressed patients.  
Several reports using proton magnetic resonance spectroscopy (1H-MRS) have also 
demonstrated that patients suffering from psychiatric disorders have decreased amounts of N-
acetylaspartate (NAA) in several brain areas relevant to cognitive performance, including the 
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hippocampus (Buckley et al., 1994; Bertolino et al., 1998; Gonul et al., 2006). NAA is a 
metabolite exclusively found in neurons (Birken and Oldendorf, 1989; Moffett et al., 1991), 
which is decreased in association with cellular dysfunction and neuronal loss (Demougeot et al., 
2001). NAA is therefore considered to be a maker of neuronal integrity. We therefore assessed 
the NAA levels in the hippocampus and PFC of the SR mouse lines (see paper III). 
Studies conducted on humans, non-human primates and rodents have previously shown 
that excess glucocorticoid exposure can reduce both the volume and activity, measured by blood 
flow, of the hippocampus (Endo et al., 1997; Bremner et al., 2000; Czeh et al., 2006). Therefore, 
in addition, mice from the three SR lines were injected with Mn2+ in order to assess the 
manganese enhanced signal intensity, as a measure of neuronal activity of these brain areas and to 
enable voxel-based morphometric studies to measure if increased glucocorticoid exposure 
decreased the volume of relevant brain areas, such as the hippocampus and PFC (see paper III). 
The dopaminergic system was furthermore investigated, as the mesolimbic dopamine 
system is strongly linked to Li and psychotic behavior in psychiatric patients (Crow et al., 1976; 
Solomon and Staton, 1982; Weiner, 1990; Davis et al., 1991; Young et al., 1993; Lubow, 2005). 
The PFC dopaminergic system reportedly also sub-serves the optimal functioning of the PFC 
(Cropley et al., 2006), which is relevant to the reversal learning task. In situ hybridization 
histochemistry was employed to semi-quantify the dopamine 1 receptor (D1R), dopamine 2 
receptor (D2R) and dopamine transporter (DAT) mRNA levels in the mesolimbic area and PFC, 
of mice from the three breeding lines (see paper II). The dopaminergic system also represents an 
interesting candidate in the search for new drug targets that can be used to treat the cognitive 
deficits in MD, as well as treatment resistant MD, as atypical antipsychotics have shown great 
promise in treating depressed patients who do not respond to typical antidepressants (Quintin and 
Thomas, 2004).  
Once certain cognitive and molecular differences were established between the three 
breeding lines of the SR mouse model, the hippocampal proteome was screened in order to use an 
unbiased approach to find new protein candidates or pathways of relevance to MD and SZ (see 
paperIII).
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DISCUSSION 
 
In this body of work, the stress reactivity (SR) mouse line has been characterized with respect to 
cognitive abilities and underlying functional alterations, with the aim of modeling cognitive 
symptoms of psychiatric diseases in order to gain insight into the molecular underpinnings of 
theses symptoms. The highly stress reactive (HR) mouse line show several cognitive deficits 
which are similar to those observed in patients suffering from major depression (MD) and 
schizophrenia (SZ). These cognitive deficits include hippocampus-dependent tasks (papers I & 
III), prefrontal cortex- (PFC) dependent tasks (see papers II & III) and disrupted latent inhibition 
(Li) (see paper II). Furthermore, the HR mice display similar alterations in brain structures that 
are presumed to be responsible for the cognitive deficits in MD and SZ, including decreased 
brain-derived neurotrophic factor (BDNF) levels in the hippocampus (see paper I), decreased N-
acetylaspartate (NAA) levels in the Hippocampus and PFC (see paper III) and alterations of the 
dopaminergic system (see paper II). In addition, proteins involved in energy metabolism have 
been found to differ between HR and low (LR) stress reactive mice, which proposes a mechanism 
whereby glucocorticoids may damage the brain (paper III).  
 
 
A GENETIC PREDISPOSTION FOR INCREASED STRESS REACTIVITY 
The HR mice are unique in the aspect that they are genetically predisposed for an increased 
hypothalamus-pituitary-adrenal (HPA) axis reactivity. The brains of HR mice are not exposed to 
excess glucocorticoids by means of repeatedly exposing them to synthetic glucocorticoids or 
specific stressors, instead each exposure to a normal life event that causes an activation of the 
HPA axis, such as an agonistic interaction with a conspecific, handling or cage changing, would 
lead to a higher exposure of the brain to glucocorticoids in HR mice compared to LR or IR mice. 
This resembles a more natural situation, as vulnerability to affective disorders in genetically 
predisposed individuals is believed to be related to heightened stress sensitivity (Nemeroff and 
Vale, 2005).  
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MODELLING COGNITIVE DEFICITS IN PSYCHIATRIC DISORDERS 
We have shown that HR mice have deficits in two hippocampus-dependent tests, the novel object 
recognition task and the Y-maze task (see papers I & III). Furthermore, HR mice showed reversal 
learning deficits indicative of poor PFC function (see papers II & III). In similarity, patients 
suffering from MD commonly exhibit deficits in hippocampus-dependent tasks, such as verbal 
memory as well as deficits in PFC-dependent executive functioning tasks (Austin et al., 2001; 
Porter et al., 2003; Reppermund et al., 2007; Rabin et al., 2009; Reppermund et al., 2009; 
Shirayama et al., 2009). Interestingly these cognitive deficits are reportedly worse in patients with 
psychotic MD (Cornell et al., 1984; Austin et al., 1999; Basso and Bornstein, 1999). This is of 
particular interest as HR mice additionally show cognitive deficits associated with psychotic 
behavior, namely disrupted Li (see paper II) (Gray et al., 1992; Gray et al., 1995; Lubow et al., 
2000; Rascle et al., 2001). The HR mice also demonstrate certain morphological alterations that 
are specifically related to patients suffering from SZ, a disorder with prominent psychotic 
features. These alterations include increased dopamine 2 receptors in the NAc and decreased 
dopamine 1 receptors in the PFC in HR mice in comparison to LR mice (see paper II), which 
mimics what is observed in patients suffering from SZ (Carlsson and Lindqvist, 1963; Carlsson et 
al., 2000; Mawlawi et al., 2001; Abi-Dargham, 2003; Alves Fda et al., 2008). HR mice thus 
demonstrate both construct and face validity as a model of psychotic behavior.  
Interestingly, patients suffering from MD as well as patients suffering from SZ have 
repeatedly been reported to have an increased HPA axis activity (Holsboer, 2000; Muck-Seler et 
al., 2004; Ryan et al., 2004; Ising et al., 2005; Ritsner et al., 2007). In patients suffering from MD 
this is specifically associated with memory deficits, psychotic features and the melancholic 
subtype of depression (Belanoff et al., 2001; Gold and Chrousos, 2002; Bremner et al., 2004; 
Gomez et al., 2006). 
Cognitive deficits and psychotic behavior can thus be seen as a cluster of symptoms 
associated with an increased HPA axis activity in psychiatric diseases including SZ, melancholic 
MD and psychotic MD. Our findings furthermore suggest that these symptoms have a common 
biological underpinnings brought about by excessive glucocorticoid exposure. The HR mice can 
be used as a model of these specific phenotypic endpoints relevant to MD and SZ and to discover 
by which means glucocorticoids contribute to these symptoms. 
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THE EFFECT OF EXCESS GLUCOCORTICOID EXPOSURE ON THE 
HIPPOCAMPUS 
Excess glucocorticoid exposure has been associated with global changes to the hippocampus, 
including decreased birth of new granular cells in the dentate gyrus of the hippocampus, dendritic 
atrophy in the CA3 region of the hippocampus and reduced hippocampal volume (Sapolsky et al., 
1990; Watanabe et al., 1992; Sousa et al., 1999; McKittrick et al., 2000; Lyons et al., 2007). 
Clinical studies have found contradicting results regarding hippocampal volume in MD with 
some studies indicating that patients suffering from unipolar depression have reduced 
hippocampal volume in comparison with healthy controls (Bremner et al., 2000; Campbell et al., 
2004; Kaymak et al., 2009; McKinnon et al., 2009) and others reporting no such difference 
(Keller et al., 2008; Bearden et al., 2009; Kronmuller et al., 2009).  
We therefore investigated if the increased glucocorticoid exposure of the hippocampus of 
HR mice had led to global morphological changes. This study revealed that the volume of the 
hippocampus was not decreased in HR mice in comparison to IR and LR mice (see paper III). 
However, both BDNF (see paper I) and NAA levels were decreased in the hippocampus of HR 
mice (see paper III). This indicates that the deficits in hippocampus-dependent learning tasks 
observed in HR mice are presumably not due to a global deterioration of the entire hippocampal 
structure, but are more likely due to more discrete morphological changes or changes occurring 
on the level of cellular processes.  
 
 
THE EFFECT OF GLUCOCORTICOID EXPOSURE ON CELLULAR FUNCTIONS 
There are theories as to how excess glucocorticoids lead to suboptimally functioning neurons. 
One central dogma in these theories is calcium induced neuronal cell damage, via glutamatergic 
hyper-activation, as glucocorticoids increase free cytosolic calcium (Elliott and Sapolsky, 1992, 
1993). The majority of receptors at the synapses of the hippocampus are glutamatergic (Lee et al., 
1991). Binding of glutamate to glutamate receptors activates N-methyl-D-aspartate receptors, 
which in turn leads to the mobilization of free cytosolic calcium. This calcium is believed to be 
responsible for activating the long-term changes that constitute “memory”. However, if the 
amounts of glutamate are excessive, this calcium mobilization produces an over-activity of 
calcium-dependent enzymes that leads to cytoskeletal degradation, protein malfolding and 
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oxygen radical generation. These processes together are detrimental for the cells functioning (Lee 
et al., 2002).  
Energy availability is also believed to be a key regulatory mechanisms in neuronal 
function (Beal et al., 1993; Turski and Turski, 1993). As a strategy to divert energy toward using 
muscles during a stressor, glucocorticoids inhibit glucose transport in various peripheral tissues 
(Munck, 1971). A similar mechanism has been proposed to occur in the hippocampus. 
Glucocorticoids decrease glucose uptake in cultured neurons and glia cells, and decrease local 
glucose utilization in the hippocampus (Kadekaro et al., 1988; Horner et al., 1990; Virgin et al., 
1991; Freo et al., 1992; Doyle et al., 1993). This reduction in glucose reduces the capacity of 
neurons and glia cells to remove glutamate from the synaptic cleft and the capacity of the cells to 
remove calcium from the cytoplasm, as both of these processes are highly energy costly (Lee et 
al., 2002). Alterations in proteins involved in energy metabolism in HR mice could thus 
potentially be a key factor in the decreased functioning of the hippocampus.  
 
 
MITOCHONDRIAL DYSFUNCTION IN PSYCHIATRIC DISORDERS 
The hippocampal proteomes of HR and LR mice were compared in order to use an unbiased 
approach to investigate if hippocampal-dependent learning deficits and decreased NAA levels 
were dependent on alterations in specific cellular processes. This comparison revealed differences 
in numerous proteins involved in energy metabolism (see paper III). Interestingly, these proteins 
appear to directly or indirectly be inducers of apoptosis and are up-regulated in HR mice in most 
cases.  
Mitochondrial dysfunction in psychiatric disorders has been the focus of many recent 
studies (Jou et al., 2009; Rezin et al., 2009a) as post mortem studies of patients suffering from 
MD and SZ have reported alterations in proteins involved in energy metabolism (Beasley et al., 
2006; Martins-de-Souza et al., 2009). Studies using animal models of depression where rats are 
subjected to chronic stress have also reported mitochondrial dysfunction and inhibition of the 
mitochondrial respiratory chain (Madrigal et al., 2001; Rezin et al., 2008; Rezin et al., 2009b) 
thus confirming a link between glucocorticoid exposure and mitochondrial dysfunction.  
The number and density of the mitochondria in patients suffering from psychiatric 
diseases have also been found to be altered. A study by Uranova and colleagues found a 
significant decrease in mitochondria number and density in the PFC and caudate nucleus of 
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postmortem brains of subjects suffering from SZ in comparison to controls (Uranova et al., 
2001). It has also been suggested that drug treatment increases the number of mitochondria in 
patients suffering from SZ (Inuwa et al., 2005). Studies have also been conducted on animals 
implicating mitochondrial energy metabolism as a target for certain mood stabilizing drugs, such 
as lithium and valproate (Wang et al., 2004; Zarate et al., 2006).  
The mitochondria are consequently a potential new target for drugs to treat MD and SZ. 
HR mice provide an excellent tool in the search for such drug targets and in the evaluation of new 
treatment strategies focusing on mitochondrial dysfunction. 
 
 
THE NEUROTROPHIC HYPOTHESIS OF MAJOR DEPRESSION 
Glucocorticoids have also been proposed to exert their detrimental effects on the hippocampus 
via other pathways than those mentioned above. The neurotrophic hypothesis of depression states 
that stress-induced vulnerability and the therapeutic action of antidepressant treatments occur via 
intracellular mechanisms that decrease or increase, respectively, neurotrophic factors necessary 
for the survival and function of particular neurons (Duman et al., 1997). The neurotrophic factor 
that has most prominently been implicated in MD is BDNF (Castren et al., 2007). BDNF is 
reportedly decreased in the plasma of depressed patients and the levels tend to increase in 
response to treatment with antidepressants (Nibuya et al., 1996; Santarelli et al., 2003; Lee et al., 
2007; Huang et al., 2008; Monteleone et al., 2008).  
Reduced BDNF levels have also been implicated in the pathophysiology of SZ. BDNF 
plasma levels and cerebrospinal fluid levels were significantly lower in first-episode patients 
diagnosed with SZ in comparison to healthy controls (Chen da et al., 2009; Pillai et al., 2010). 
Plasma levels of BDNF have also been shown to be decreased in chronic patients with SZ (Xiu et 
al., 2009). Interestingly, the plasma levels vary in accordance with the medication with which 
these patients were treated. Patients treated with risperidone had lower plasma levels of BDNF 
than those treated with clozepine and typical antipsychotics (Xiu et al., 2009). However, in 
contrast to MD the improvement of SZ symptoms has not been associated with increased BDNF 
levels (de Lucena et al.).  
The decreased amounts of BDNF in the hippocampus of HR mice (see paper I) thus 
provide further support to the assumption that there is a common underlying mechanism of the 
cognitive deficits in MD, SZ and the cognitive deficits observed in HR mice, presumably brought 
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about by increased HPA axis activity and decreased BDNF levels. These findings also support the 
hypothesis that increased exposure to glucocorticoids leads to decreased BDNF levels and show 
that the HR mice can be used in the search for new treatment strategies aiming at increasing 
BDNF levels.  
 
 
THE ASSOCIATION BETWEEN ENERGY METABOLISM, BRAIN-DERIVED 
NEUROTROPHIC FACTOR AND N-ACETYLASPARTATE LEVELS  
It has been suggested that alterations of neurotrophic or neuroprotective factors may be the 
underlying cause of lower hippocampal NAA levels that have been reported in several psychiatric 
disorders including bipolar disorder (BPD) (Deicken et al., 2003) unipolar depression and SZ 
(Buckley et al., 1994; Bertolino et al., 1998; Gonul et al., 2006). This is particularly interesting as 
the HR mice not only have decreased BDNF in the hippocampus (see paper I), but were also 
found to have decreased NAA levels in the hippocampus (see paper III). A positive correlation 
between plasma BDNF and NAA levels in the anterior cingulate cortex has been reported in 
healthy controls (Lang et al., 2007). Furthermore, a single nucleotide polymorphism (SNP) that 
results in decreased BDNF levels has been associated with decreased NAA levels in humans 
(Gallinat et al., 2010). This SNP encodes a Valine or Methionine at amino acid 66 of the gene 
product, where the Methionine allele has been associated with increased risk of MD (Gatt et al., 
2008), poorer episodic memory, abnormal hippocampal activation, assayed with fMRI, and lower 
hippocampal NAA, assayed with MRI spectroscopy (Egan et al., 2003). This demonstrates that 
the link between memory deficits, NAA levels and BDNF that we observe in HR mice is also 
present in patients, lending further support to the validity of this mouse model.  
BDNF is known to inhibit apoptosis in the granular cells of the hippocampus (Kubo et al., 
1995). Thus, decreased BDNF in the hippocampus of HR mice may be a mechanism whereby the 
apoptosis inducing proteins are upregulated in HR mice. Decreased NAA levels have also been 
proposed to be associated with decreased energy metabolism in neurons (Signoretti et al., 2001). 
Decreased mitochondrial function or increased apoptosis may thus be the connection between 
decreased BDNF levels and decreased NAA levels reported in patients, as well as in our mouse 
model. 
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ADVANTAGES OF THE STRESS REACTIVITY MODEL 
There are several well established animal models of depression, however, the SR mouse model 
has the advantage of having a more natural etiology in comparison with models where mice are 
repeatedly stressed or models where genes are overexpressed or knocked out. A further advantage 
of the SR mouse model, in comparison with models using genetic engineering techniques, is that 
the SR mouse lines are derived from an outbred mouse line. This means that the phenotypes we 
observe are independent of a homogenous genetic background. This is an important factor to 
consider as the same gene knocked out in different mouse lines can lead to entirely different 
phenotypes (Banbury_Conference, 1997; Lesch and Mossner, 1998). The SR mouse model thus 
has the added advantage of being more analogous to psychiatric disorders in that the HR mice 
show similar phenotypic endpoints to patients suffering from MD and SZ, driven from a variable 
genetic background, where a multitude of genes contribute to the observed endophenotype. 
The approach of breeding lines of mice that will develop a known disease-like state also 
allows the investigation of the development of the disease over time. The HR mice can be utilized 
in future studies to investigate if the hippocampus is functioning suboptimally at birth or if these 
differences occur as a cumulative effect of exposure to excess amounts of glucocorticoids across 
their lifespan. Top down approaches going from a known behavior to screening of the genome or 
proteome are a further advantage of the model. This approach allows for an unbiased approach to 
finding new candidate proteins or genes that are important in the development of affective 
disorders.  
 
 
OUTLOOK AND CONCLUDING REMARKS 
There are ample opportunities to put the stress reactivity mouse model to use in future 
experiments aimed at discovering the molecular underpinnings of affective disorders such as MD 
and SZ. As the behavioral phenotype has now been extensively characterized, along with certain 
similarities in underlying mechanisms of cognitive deficits in MD and SZ, future findings of 
genetic or proteomic differences between HR an LR mice may be extrapolated to be relevant to 
patients suffering from MD an SZ. The first screening of the hippocampal proteome has thus far 
produced some highly interesting candidates and systems for further investigation. As most of the 
proteins revealed to differ between HR and LR mice were involved in energy metabolism, 
specifically screening the mitochondrial proteome would be of great interest, as well as 
 
Discussion  30
 
 
sequencing the mitochondrial DNA in order to discover if the origin of differences in protein 
expression are brought about by differences on the DNA level, or by downstream mechanisms 
that regulate gene expression, such as transcription factors activated by glucocorticoids. Proteins 
that are found to differ in the adult could then be investigated early in life or in the embryonic 
stage, in order to discover if these protein differences are the cause or effect of the stress 
reactivity phenotype. 
 The results reported here show that the SR mouse lines have good construct and face 
validity as a mouse model of affective disorders and can be used to further our understanding of 
the underlying mechanisms of the symptoms of these disorders as well as in the search for better 
treatment options for SZ and MD.  
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Cognitive deﬁcits are a common feature of major depression (MD), with largely unknown biological
underpinnings. In addition to the affective and cognitive symptoms of MD, a dysregulation of the hypo-
thalamic–pituitary–adrenal (HPA) axis is commonly observed in these patients. Increased plasma gluco-
corticoid levels are known to render the hippocampus susceptible to neuronal damage. This structure is
important for learning and memory, creating a potential link between HPA axis dysregulation and cog-
nitive deﬁcits in depression. In order to further elucidate how altered stress responsiveness may contrib-
ute to the etiology of MD, three mouse lines with high (HR), intermediate (IR), or low (LR) stress reactivity
were generated by selective breeding.
The aim of the present study was to investigate whether increased stress reactivity is associated with
deﬁcits in hippocampus-dependent memory tests. To this end, we subjected mice from the HR, IR, and LR
breeding lines to tests of recognition memory, spatial memory, and depression-like behavior. In addition,
measurements of brain-derived neurotrophic factor (BDNF) in the hippocampus and plasma of these ani-
mals were conducted.
Our results demonstrate that HR mice exhibit hippocampus-dependent memory deﬁcits along with
decreased hippocampal, but not plasma, BDNF levels. Thus, the stress reactivity mouse lines are a prom-
ising animal model of the cognitive deﬁcits in MD with the unique feature of a genetic predisposition for
an altered HPA axis reactivity, which provides the opportunity to explore the progression of the symp-
toms of MD, predisposing genetic factors as well as new treatment strategies.
 2009 Elsevier Ltd. All rights reserved.1. Introduction releasing hormone (CRH) system along with other symptoms char-Patients suffering from MD often complain of cognitive impair-
ment, mainly memory impairment and executive functioning def-
icits (Austin et al., 2001; Porter et al., 2003; Reppermund et al.,
2007). It has been reported that divided attention and verbal work-
ing memory deﬁcits were present in the majority of subjects, both
on admission and at discharge (Reppermund et al., 2007). Further-
more, low episodic memory performance in healthy subjects has
been associated with an increased risk of developing depression,
and can thus be seen as a premorbid marker of MD (Airaksinen
et al., 2007).
There are also physiological correlates of MD, such as a dysreg-
ulation of the hypothalamus–pituitary–adrenal (HPA) axis. MD is
generally associated with a hyperresponsive HPA axis (Holsboer,
2000; Ising et al., 2005). However, there are also depressed patients
exhibiting a hypofunction of the hypothalamic corticotrophin-ll rights reserved.
.
napman).acteristic of this subtype of MD (Angst et al., 2002; Antonijevic,
2006; Gold and Chrousos, 2002; Gold et al., 1995). In the context
of cognitive deﬁcits in MD, it is relevant to distinguish between
the patients with a hypoactive and hyper-active HPA axis as cogni-
tive dysfunction, in particular memory deﬁcits, have been associ-
ated with hypercortisolemia in depressed patients (Belanoff
et al., 2001; Bremner et al., 2004). The relationship between mem-
ory dysfunction and hypercortisolemia is presumably brought
about by the negative inﬂuence of glucocorticoids on the hippo-
campus, a structure that is important for learning and memory
(Eichenbaum, 2000; Sapolsky et al., 1990; Scoville and Milner,
1957). Repeated stress and chronically increased glucocorticoid
levels have been reported to be associated with a reduction in hip-
pocampal volume, dendritic atrophy in the CA3 region of the hip-
pocampus and reduced birth of new granule cells in the dentate
gyrus of the hippocampus (Lyons et al., 2007; McKittrick et al.,
2000; Sapolsky et al., 1990; Sousa et al., 1999; Watanabe et al.,
1992). Using in vivo imaging, hippocampal volume has been found
to be decreased in patients suffering from MD (Bremner et al.,
A. Knapman et al. / Journal of Psychiatric Research 44 (2010) 566–575 5672000; Frodl et al., 2006; Holsboer and Ising 2010; MacQueen et al.,
2003; Sheline et al., 1996) and in patients suffering from Cushing’s
syndrome, where hypercortisolemia is a cardinal symptom (Stark-
man et al., 1992).
Glucocorticoids have an acute effect on memory processing.
Stress and glucocorticoids are believed to enhance memory consol-
idation, whereas increased glucocorticoid levels impair memory
retrieval (Buchanan and Lovallo, 2001; de Quervain et al., 1998;
Flood et al., 1978; Holsboer and Ising, 2010; Kovacs et al., 1977;
Kuhlmann and Wolf, 2006; Oitzl et al., 1998; Roozendaal, 2000).
The effects of stress on memory function are also dependent on
the type of memory being studied (Luethi et al., 2008). Further-
more, studies using a standardized psychosocial stressor have con-
ﬁrmed a correlation between cortisol reactivity and memory
impairment in healthy adults (Kirschbaum et al., 1996).
Moreover, studies on rodents have shown that glucocorticoid
excess decreases the level of brain-derived neurotrophic factor
(BDNF) in the hippocampus (Jacobsen and Mork, 2006; Murakami
et al., 2005; Schaaf et al., 1998, 1997), which has been strongly
implicated in the regulation of hippocampal long-term potentia-
tion (LTP) (Chen et al., 1999; Korte et al., 1996; Patterson et al.,
1996). Reduced hippocampal BDNF levels have furthermore been
shown to impair memory performance in a number of animal stud-
ies (Gorski et al., 2003; Monteggia et al., 2004; Schaaf et al., 2001).
Interestingly, BDNF levels are also reduced in the plasma of de-
pressed patients and tend to increase in response to antidepressant
treatment (Huang et al., 2008; Lee et al., 2007; Monteleone et al.,
2008; Nibuya et al., 1996; Santarelli et al., 2003). It is believed that
said increase in BDNF may play a key role in the effectiveness of
the antidepressant treatment (Wang et al., 2008). However, the
changes in brain BDNF concentration demonstrated in animal
studies and the plasma BDNF concentrations of patients may
merely reﬂect the treatment-induced decrease in plasma cortico-
sterone/cortisol level (Greden et al., 1983; Holsboer et al., 1982; Is-
ing et al., 2007). Furthermore, low plasma BDNF levels have been
associated with memory impairment in MD (Grassi-Oliveira
et al., 2008). However, it is important to note that plasma BDNF
levels are not necessarily a reﬂection of brain BDNF levels.
The aim of the present study was to further the understanding
of the relationship between HPA axis hyperresponsiveness or hyp-
oresponsiveness and memory function. We approached this ques-
tion by using a recently established animal model generated by
selectively inbreeding mice for extremes in stress reactivity (Tou-
ma et al., 2008). A founder population of CD-1 mice was subjected
to a standardized stressor (15 min restraint stress) and their HPA
axis reactivity in response to this stressor was determined by sub-
tracting the corticosterone level of the initial blood sample, taken
before the stressor, from the corticosterone level of a blood sample
taken immediately after the restraint stress. Males and females
with very high stress reactivity (HR) were then mated, as were
males and females with extremely low stress reactivity (LR). Their
offspring were tested for their stress reactivity in the same manner
and so forth for each generation to come (for details see (Touma
et al., 2008)). An intermediate (IR) reactivity line was additionally
established to serve as a control group with the same inbreeding
status as the other two lines. The IR mice present a corticosterone
response similar to the mean of the founder population of CD-1
mice (Touma et al., 2008).
These mouse lines have previously been characterized with re-
spect to several endophenotypes relevant to MD. In summary, the
HR mice display several characteristics found in patients suffering
from melancholic depression, such as a hyperreactive HPA axis, a
ﬂattened circadian glucocorticoid rhythm, a hyper-active coping
style, increased rapid eye movement sleep, and decreased body
weight. On the other hand the LR mice display similarities to the
atypical subtype of depression, such as a hyporeactive HPA axis,a more passive coping style, increased aggressive behavior and in-
creased body weight (Touma et al., 2008, 2009). In order to inves-
tigate the cognitive abilities of this stress reactivity mouse model,
we implemented a novel object recognition test to assess recogni-
tion memory and a Y-maze free choice exploration paradigm to as-
sess spatial learning (Dellu et al., 2000). Furthermore, coping
behavior was assessed using the forced swim test (FST). When
the behavioral testing was completed the brains were collected
and the amount of BDNF in the hippocampus was quantiﬁed.
The great advantage of this mouse model over others investi-
gating the role of the HPA axis in depression is that it allows for
the investigation of two pathological states i.e. an extremely high
HPA axis reactivity and an extremely low HPA axis reactivity. In
addition, it is possible to apply a top down approach and go from
a known endophenotype to investigate the genotype. Another un-
ique advantage is that knowing that the animals from a speciﬁc
line will develop a certain phenotype enables the possibility to
study the progression of the symptoms of the disease.2. Methods
2.1. Subjects
Animals derived from the eighth generation of the stress reac-
tivity (SR) mouse model (for details see (Touma et al., 2008)) were
used in these experiments. Twelve male and 12 female mice from
the HR, IR, and LR breeding lines, were selected according to their
corticosterone increase in the stress reactivity test (SRT) (described
below). In order to control for litter effects the mice were selected
from a minimum of six different litters per line. During the behav-
ioral testing period, animals were single housed in transparent
polycarbonate cages (standard macrolon cages type II,
26  20  14 cm) with food and water available ad libitum. A
12:12 h light–dark cycle with lights on at 8 a.m. was maintained
throughout breeding and testing. The housing rooms and experi-
mental rooms were kept at a constant temperature (22 ± 1 C)
and humidity (55 ± 10%). Animals were between 3 and 5 months
of age during the period of behavioral testing. All experiments
were performed during the trough of the circadian rhythm of glu-
cocorticoid secretion (between 9 and 12 a.m.) and the order of test-
ing was counterbalanced across the different breeding lines.
The presented work complies with current regulations covering
animal experimentation in Germany and the EU (European Com-
munities Council Directive 86/609/EEC). All experiments were an-
nounced to the appropriate local authority and were approved by
the ‘Animal Welfare Ofﬁcer’ of the Max Planck Institute of
Psychiatry.2.2. Stress reactivity test and plasma corticosterone measurements
At the age of approximately 8 weeks, the mice were subjected
to a stress reactivity test (SRT) in order to assess the reactivity of
their hypothalamic–pituitary–adrenal (HPA) axis. The SRT is de-
scribed in detail elsewhere (Touma et al., 2008). Brieﬂy, an initial
blood sample for corticosterone measurement was collected from
a small incision in the ventral tail vessel. The mouse was then
placed in a restraint tube for 15 min. Following the restraint stress,
a second blood sample, the reaction sample, was obtained from a
second incision in the tail vessel. The corticosterone increase in re-
sponse to this stressor was calculated by subtracting the cortico-
sterone concentration in the initial sample from the
corticosterone concentration in the reaction sample.
Plasma corticosterone concentrations were determined using a
commercial radioimmunoassay (RIA) kit (MP Biomedicals, Solon,
Ohio, USA), with slight modiﬁcations to the manufacturer’s
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assay coefﬁcients of variation were both below 10%.2.3. Y-maze Test
The Y-maze was used to assess spatial memory (Dellu et al.,
2000). The apparatus used for this test was Y-shaped and con-
structed from grey plastic. It consisted of three 11 cm wide and
30 cm long arms with 15 cm high walls at equal distance from each
other, connected by a central zone. The spatial orientation of the
mice was facilitated by each individual arm bearing a different
symbol on the walls in the shape of a bar, a plus or a triangle.
During the acquisition phase one arm was blocked by a plastic
partition wall. The mouse was placed in the central area of the
maze facing the corner connecting the two accessible arms to en-
sure that the animal was not inﬂuenced to choose a speciﬁc arm
due to the direction in which it was facing when placed in the
maze. The animal was then allowed to explore the maze for
10 min. The maze was cleaned with soapy water and alcohol and
thoroughly dried between test animals. After an inter-trial interval
(ITI) of 60 min, where the mouse was returned to its home cage,
the mouse was placed back in the maze, this time with the oppor-
tunity to explore all three arms. This retrieval phase lasted for
5 min.
If the mouse is able to discriminate between the novel and
familiar arms, a preference towards exploring the arm that was
blocked during the acquisition phase, i.e. the novel arm, will be re-
ﬂected in an increased amount of time spent in this arm. The ani-
mals’ movements were tracked using ANY-maze software (ANY-
maze, Stoelting Co., IL, USA). To eliminate the effect of differences
in locomotion between the lines, the mean percent time spent in
the familiar arms was compared to the percent time spent in the
novel arm. If the animals spent signiﬁcantly more time in the novel
arm compared to the mean of the familiar arms, they were as-
sumed to have remembered the arms they had previously been al-
lowed to explore.2.4. Novel object recognition test
The novel object recognition (NOR) test assesses the animal’s vi-
sual and tactile recognition memory and takes advantage of ro-
dents innate behavior to spend more time investigating a novel
object than one previously encountered (reviewed in (Eichenbaum
et al., 2007)). The NOR test was carried out in black plastic testing
cages measuring 21.5  38  35 cm, covered with a thin layer of
sawdust. Animals were habituated to the test cage for 1 h preced-
ing the acquisition phase. During the acquisition phase of the test,
mice were presented with an object and allowed to explore it for
the duration of 5 min. The retrieval phase consisted of a copy of
the familiar object, the one that was presented during the acquisi-
tion phase, being presented together with a novel object. The mice
were then allowed to explore both objects for 5 min. During the in-
ter-trial interval (ITI) between the acquisition phase and the test
phase, mice were left undisturbed in the testing cages.
Each animal was tested with three different ITIs; 30, 60, and
120 min, with 2 days between test days. Three pairs of objects
were used for the test (Supplementary Fig. 1). All objects were of
similar size and constructed from Lego blocks (LEGO, Lego Group,
Bilund Denmark). A different group of mice were used to verify
that there was no innate preference or aversion to any of the cho-
sen objects (data not shown). Any individual mouse was only pre-
sented with a certain pair of objects on one occasion. Which object
was the novel object and which was the familiar object as well as
the use of the different pairs was counterbalanced across the
groups and ITIs.The amount of time spent exploring each of the objects was vid-
eotaped and subsequently manually scored by a trained observer
blind to the animals’ experimental groups. Exploration was deﬁned
as the animal having a proximity to the object of no more than one
centimeter with its head facing the object. Animals with an explo-
ration time below 10 s during the acquisition phase or retrieval
phase were excluded from the analysis. The animals were assumed
to have remembered the familiar object if signiﬁcantly more time
was spent exploring the novel object.
2.5. Forced swim test
In order to assess coping strategies in aversive situations, the
forced swim test (FST) was used (Porsolt et al., 1977). Each mouse
was placed in a glass cylinder (12 cm in diameter and 24 cm high)
ﬁlled to two thirds with 23 C water for 6 min. All sessions were vi-
deo recorded, and the animals’ behavior was subsequently scored
by a trained observer to determine the amount of time spent
swimming, ﬂoating and struggling. For precise behavioral deﬁni-
tions (see Touma et al., 2008). In this test, an increased amount
of immobility is classically regarded as behavioral despair, which
can be interpreted as depression-like behavior.
2.6. Brain collection
The brains and plasma samples of all experimental animals
were collected 4 weeks after the last behavioral test. Animals were
brieﬂy anesthetized with isoﬂurane before decapitation. The brains
were quickly removed and cut in half separating the left and right
hemisphere, in order to collect the hippocampus. Due to the possi-
bility of lateralization, the left hippocampus was dissected from
half of the animals from each group and the right hippocampus
from the other half. All samples were stored at 80 C until they
were further processed.
2.7. Determination of BDNF protein
The content of endogenous BDNF was quantiﬁed in the plasma
and hippocampal samples via an enzyme-linked immunosorbent
assay (ELISA) using commercially available antibodies (Promega,
Madison, WI, USA). The procedure is described in detail elsewhere
(Hellweg et al., 2006, 2003). One IR male died before brain collec-
tion and one sample per line out of the males had too small
amounts of tissue to be considered a valid measurement. Within
the females, two samples from the IR line were excluded due to
the same reason.
2.8. Statistical analysis
Non-parametric statistics were used to analyze all behavioral
tests as the data was not normally distributed in all cases. Differ-
ences between more than two independent samples were com-
pared using the Kruskal–Wallis H-test (KWH-test). When
signiﬁcance was reached, post-hoc comparisons between two inde-
pendent groups were performed using Mann–Whitney U-tests
(MWU-test). Bonferroni correction was applied to correct for re-
peated testing. In order to compare two dependent samples, the
Wilcoxon-test (W-test) was applied. Corticosterone and BDNF
measurements were analyzed using parametric statistics, as these
data sets were found to be normally distributed. In order to com-
pare differences between more than two independent samples,
one factor analysis of variance (ANOVA) was followed by Tukey’s
post-hoc test. The association between the corticosterone increase
in the SRT and hippocampal BDNF levels was analyzed using Pear-
son’s correlation coefﬁcient.
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(version 16.0, SPSS Inc., Chicago, IL, USA) and statistical signiﬁ-
cance was set at p < 0.05, however, p < 0.1 was considered a trend.
Two-tailed p-values were reported in all cases except for the Y-
maze test and the object recognition test, in which the outcome
was predicted with a one-sided hypothesis, making the use of a
one-tailed p-value appropriate.Fig. 2. Percent time spent exploring the novel arm compared to the mean of the
two familiar arms in the Y-maze spatial learning task in male and female mice
selectively bred for high (HR), intermediate (IR), and low (LR) stress reactivity.
Signiﬁcantly more time spent exploring the novel arm indicates that the animal
remembered the familiar arm (W-test, p < 0.05*, p < 0.01**, p < 0.1T). Data are given
as box plots showing medians (lines in the boxes), 25% and 75% percentiles (boxes).
The 10% percentile and 90% percentile are indicated by the whiskers.3. Results
3.1. Stress reactivity test
Highly signiﬁcant differences in the restraint stress-induced
corticosterone increase were present between the three lines in
males and females (males: F(2,33) = 112.0, p < 0.001; females:
F(2,33) = 304.5, p < 0.001; Tukey’s post-hoc; males: all p < 0.001; fe-
males: all p < 0.001; Fig. 1). This is in accordance with ﬁndings in
previous generations of the stress reactivity mouse model (Touma
et al., 2008). The three lines furthermore differed in their cortico-
sterone levels in the initial blood sample taken in the SRT, with
the highest levels found in the HR mice and the lowest levels in
the LR mice (mean ± SEM: males: HR: 6.1 ± 2.2 ng/ml, IR:
4.7 ± 1.7 ng/ml, LR: 1.5 ± 0.2 ng/ml; females: HR: 41.6 ± 8.7 ng/ml,
IR: 30.7 ± 4.3 ng/ml, LR: 9.7 ± 2.7 ng/ml). These effects were statis-
tically signiﬁcant (3(line)  2(sex) ANOVA, F2,66 line = 9.434, p <
0.001, F1,66 sex = 44.279, p < 0.001, F2,66 line  sex = 5.232, p = 0.008;
Tukey’s post-hoc; males: all p > 0.1; females: HR vs. LR: p < 0.01,
HR vs. IR: p < 0.1, IR vs. LR: p < 0.05). This is in accordance with
ﬁndings in previous generations and can be attributed to the in-
creased trough levels of the circadian rhythm of glucocorticoid
secretion observed in HR mice (Touma et al., 2008, 2009).3.2. Y-maze test
Male LR mice displayed a superior performance in the Y-maze
spatial learning test compared to both IR and HR mice. After the
1 h inter-trial interval (ITI), only the LR mice spent a signiﬁcantly
larger percent time exploring the novel arm than the mean of
the familiar arms, demonstrating a recognition of the previouslyFig. 1. Corticosterone increase in response to 15 min restraint in male and female
mice selectively bred for high (HR), intermediate (IR), and low (LR) stress reactivity.
The corticosterone increase differs signiﬁcantly between the three lines in both
male and female mice (ANOVA followed by Tukey’s post-hoc test, all p < 0.001***).
Data are given as box plots showing medians (lines in the boxes), 25% and 75%
percentiles (boxes). The 10% percentile and 90% percentile are indicated by the
whiskers.explored familiar arms (W-test, Z = 2.20, p < 0.05; Fig. 2). Male
IR mice showed a tendency toward spending a larger percent of
their time exploring the novel arm compared to the familiar arms,
but statistical signiﬁcance only reached trend values (W-test,
Z = 1.67, p < 0.1; Fig. 2). Male HR mice were not able to distin-
guish between the novel and familiar arms (W-test, Z = 0.86,
p > 0.1; Fig. 2).
In accordance with the results of the males, female LR and IR
mice were able to distinguish between the novel and familiar arms
of the maze and spent signiﬁcantly more time in the novel arm
compared to the mean of the familiar arms (W-test, IR:
Z = 2.98, p < 0.01; LR: Z = 2.75, p < 0.01; Fig. 2), whereas HRmice
were not able to do so (W-test, Z = 0.94, p > 0.1; Fig. 2).
3.3. Novel object recognition test
After an inter-trial interval (ITI) of 30 min, only the LR mice of
both sexes were able to distinguish between the novel and the
familiar object, demonstrated by them spending signiﬁcantly more
time exploring the novel object than the familiar object (W-test,
males: Z = 1.80, p < 0.05 and females: Z = 2.00, p < 0.05;
Fig. 3A). Female IR mice tended to explore the novel object more
than the familiar one, but statistical signiﬁcance only reached
trend values (W-test, Z = 1.80, p < 0.1; Fig. 3A). None of the
groups were able to distinguish between the novel and the familiar
object after an ITI of 1 h (Fig. 3B). However, after an ITI of 2 h the
male LR and IR mice were able to remember the familiar object
and spent signiﬁcantly more time exploring the novel object (W-
test, IR: Z = 1.84, p < 0.05; LR: Z = 1.96, p < 0.05; Fig. 3C).
The overall mean exploration times of males and females were
relatively high in comparison to many other studies using CD-1
mice or different inbred strains. Males explored on average 77 s
and females 53 s during the acquisition and retrieval phase. Abso-
lute exploration times during the acquisition phase or the retrieval
phase did not differ signiﬁcantly between the three lines in males
or females for any ITI. In males and females each ITI was compared
separately (KWH-test, H = 0.1–5.2, df = 2, all p > 0.05). In males,
during the retrieval phases corresponding to the three different
Fig. 3. Time spent exploring a novel vs. a familiar object in male and female high
(HR), intermediate (IR), and low (LR) stress reactivity mice. Signiﬁcantly more time
spent exploring the novel object is interpreted as recalling the familiar object (W-
test, p < 0.05*, p < 0.1T). Data are given as box plots showing medians (lines in the
boxes), 25% and 75% percentiles (boxes). The 10% percentile and 90% percentile are
indicated by the whiskers.
Fig. 4. Amount of time spent ﬂoating (A) and struggling (B) in the forced swim test
in mice selectively bred for high (HR), intermediate (IR), and low (LR) stress
reactivity (KWH-test, post-hoc MWU-tests; p < 0.1T, p < 0.05*, p < 0.01**,
p < 0.001***). Data are given as box plots showing medians (lines in the boxes),
25% and 75% percentiles (boxes). The 10% percentile and 90% percentile are
indicated by the whiskers.
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84–124 s and 56–78 s for HR, IR, and LR mice, respectively. In fe-
males, the mean exploration times during the retrieval phases
were slightly lower ranging from 49–66 s, 63–66 s to 48–75 s for
HR, IR, and LR mice, respectively.3.4. Forced swim test
Both male and female HR mice spent signiﬁcantly less time
immobile in the FST than IR or LR mice (KWH-test, males:
H = 15.6, df = 2, p < 0.001; females: H = 11.2, df = 2, p < 0.01; post-
hoc MWU-tests, males: U = 10–17, HR vs. IR: p < 0.05, HR vs. LR:
p < 0.001; females: U = 19–30, HR vs. IR: p < 0.05, HR vs. LR:
p < 0.001; Fig. 4A). Male HR mice also exhibited signiﬁcantly more
struggling behavior than IR or LR mice (KWH-test, H = 13.4, df = 2,
p < 0.01; post-hoc MWU-tests, U = 12–20, HR vs. IR: p < 0.05, HR vs.
LR p < 0.01; Fig. 4B). Differences in struggling times between the
three lines in the females only reached trend values (KWH-test,
H = 5.4, df = 2, p < 0.1), but the direction of the results resembled
that of the males. Male mice did not differ signiﬁcantly between
the groups in the amount of time spent swimming. However, fe-
male HR mice spent signiﬁcantly more time swimming than fe-
male LR mice (KWH-test, H = 6.6, df = 2, p < 0.05; post-hoc MWU-
tests, HR vs. LR: U = 29, p < 0.05).3.5. BDNF measurements
BDNF content in the hippocampus of HR, IR, and LR mice dif-
fered signiﬁcantly between the three lines and between the sexes,
Fig. 5. Hippocampal brain-derived neurotrophic factor (BDNF) levels in male and
female mice with high (HR), intermediate (IR), and low (LR) stress reactivity
(ANOVA, Tukey’s post-hoc test; p < 0.1T, p < 0.05*, p < 0.01**). Data are given as box
plots showing medians (lines in the boxes), 25% and 75% percentiles (boxes). The
10% percentile and 90% percentile are indicated by the whiskers.
Fig. 6. Association between corticosterone increase in the stress reactivity test
(SRT) and brain-derived neurotrophic factor (BDNF) content in the hippocampus in
males (A) and females (B) selectively bred for high (HR), intermediate (IR), and low
(LR) stress reactivity (Pearson’s correlation coefﬁcient).
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(3(line)  2(sex) ANOVA, F2,60 line = 8.313, p = 0.001, F1,60 sex =
10.728, p = 0.002, F2,60 line  sex = 0.892, p = 0.415). In both males
and females LR mice express the highest levels of BDNF and HR
mice express the lowest levels (Fig. 5). Post-hoc analysis revealed
that male HR mice express signiﬁcantly lower levels of BDNF than
LR mice, whereas there was only a tendency towards lower levels
in comparison to IR mice (HR vs. IR: p < 0.1, HR vs. LR: p < 0.05;
Fig. 5). Female HR mice also expressed signiﬁcantly less BDNF in
the hippocampus than IR mice and had a tendency towards lower
levels compared to LR mice (HR vs. IR: p < 0.05, HR vs. LR: p < 0.1;
Fig. 5).
Plasma BDNF levels, however, did not differ signiﬁcantly be-
tween the three lines, nor did they differ between the sexes
(mean ± SEM: HR: 42.6 ± 7.1 pg/ml, IR: 39.3 ± 6.3 pg/ml, LR:
26.9 ± 2.5 pg/ml; 3(line)  2(sex) ANOVA, F2,64 line = 2.167, p =
0.123, F1,64 sex = 0.103, p = 0.750, F2,64 line  sex = 1.55, p = 0.321).
In order to evaluate if corticosterone increase in the SRT is asso-
ciated with hippocampal BDNF levels, covariance between the two
factors were analyzed using Pearson’s correlation coefﬁcient. This
revealed a signiﬁcant negative correlation between corticosterone
increase in the SRT and hippocampal BDNF levels in both males
and females (males: r = 0.53, p < 0.01; females: r = 0.37,
p < 0.05; Fig. 6).4. Discussion
In this study we have demonstrated that highly (HR) stress
reactive mice suffer from object memory impairment and spatial
memory impairment, whereas mice with a low (LR) responsiveness
to stress have a superior memory compared to intermediate (IR)
stress reactive mice. These results are paralleled by ﬁndings of de-
creased hippocampal BDNF contents in HR mice and increased hip-
pocampal BDNF contents in LR mice in comparison to IR animals.
Taken together, these results demonstrate that HR mice display
cognitive deﬁcits, which could be explained by decreased BDNF
levels in the hippocampus. Furthermore, the HR/IR/LR mouse lines
differ signiﬁcantly in their coping strategies in the forced swim test
(FST).
According to our hypothesis, HR mice have an inferior perfor-
mance in memory tests due to chronic exposure to corticosteroids.
We propose that this is due to the fact that on any event that elicitsa physiological stress response such as handling, cage changing or
unavoidable noise in the animal housing facility, the hippocampus
of an HR mouse would cumulatively be subjected to larger
amounts of glucocorticoids than that of an IR or LR mouse. This
in turn could lead to long-term functional impairment of the hip-
pocampal neurons in the HR mice.
The inferior memory of the HR mice is demonstrated by the re-
sults of the Y-maze test. This is an intervalic recognition test, using
a similar approach to the procedure used in human memory stud-
ies (Dellu et al., 1992). A study using hippocampally lesioned mice
has shown that novelty preference in the Y-maze is hippocampus-
dependent (Sanderson et al., 2009). Neither male nor female HR
mice were able to successfully distinguish between novel and
familiar arms in this spatial learning test, whereas LR males and fe-
males were able to do so (see Fig. 2). IR females were also able to
successfully discriminate between the novel and familiar arms of
the Y-maze, whereas IR males only showed a tendency towards
spending more time in the novel arm during the retrieval phase.
The results of the novel object recognition (NOR) test are in
accordance with the results of the Y-maze test, with HR mice
exhibiting memory deﬁcits and LR mice showing evidence of a
superior memory performance (see Fig. 3). It is, however,
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ing and memory can be masked by acute effects, if the testing sit-
uation itself is stressful. In such cases, the acute stress response
could interfere with memory retrieval. Although being subjected
to a novel environment and introduced to new objects is not a se-
vere stressor per se, it will, however, lead to a state of arousal in the
animal, which in turn will activate the HPA axis (Okuda et al.,
2004). Furthermore, it has been shown that the acquisition phase
of the NOR test leads to an increase in corticosterone well above
baseline levels (Okuda et al., 2004; Palchykova et al., 2006). This
is apparent in the case of the 1 h inter-trial interval (ITI) of the
NOR test, where male LR mice failed to distinguish between the
two objects, although they showed a preference toward the novel
object with a 1/2 h ITI and a 2 h ITI. This ﬁnding is in concordance
with the duration and peak of the corticosterone stress response of
these mouse lines as measured by microdialysis in the hippocam-
pus (Heinzmann et al., in preparation), which indicates that the re-
trieval phase of the 1 h ITI coincides with the peak of the stress
response, with glucocorticoids presumably reaching levels that
interfere with memory retrieval. The male IR mice were similarly
unable to distinguish between the two objects after 1 h, but were
able to do so after 2 h. Furthermore, the IR mice were unable to dis-
tinguish between the two objects after 1/2 h, which could be ac-
counted for by the greater rise in glucocorticoid levels in IR mice
compared to LR mice. However, this acute effect does not confound
the entire experiment, as by the retrieval phase of the 2 h ITI all
lines should be back to baseline corticosterone levels, meaning that
the inability of the HR mice to distinguish between a novel and a
familiar object presumably does not reﬂect the acute effects of
stress, but is more likely to reﬂect a chronic exposure to increased
levels of glucocorticoids.
None of the female mice were able to distinguish between the
novel and the familiar object after one or 2 h, whereas both IR
and LR male mice were able to do so after 2 h (see Fig. 3). This is
in contradiction to most other ﬁndings, where male and female
mice have been shown to perform the test equally well (Bredy
et al., 2004; Chen et al., 2004; Clinton et al., 2007; Tordera et al.,
2007; Villasana et al., 2006). However, most of these studies used
C57BL/6 or transgenic mice on a mixed background. This could ac-
count for the differences between these results reported here and
the results of other research groups. Furthermore, the length of ITIs
used vary markedly between the studies with many experiments
using ITIs of 15 min or less and others using ITIs of 1 and 24 h,
but not investigating the time periods in-between. This does not
coincide with the time frame of the ITIs used in our experiments,
which could further explain the discrepancy between the results.
The NOR test and the Y-maze test were designed in every con-
ceivable way to not be aversive or stressful to the animals. The
tests were performed under low lighting conditions and the ani-
mals were habituated to the test setting when possible. It is, how-
ever, not possible to design a test that does not elicit any stress or
arousal in the animals as this will occur as soon as they are re-
moved from their home cage. Therefore, we can’t exclude the pos-
sibility that acute effects of the stress response are contributing to
the cognitive deﬁcits we observe in the HR mice. A decrease in
BDNF in the hippocampus of the HR mice however does support
the notion that there are changes in the hippocampus of these ani-
mals making an acute effect of glucocorticoids less plausible than a
chronic effect. Increased basal corticosterone levels in the HR mice
(Touma et al., 2008, 2009) may also contribute to the cognitive def-
icits observed in the HR mice.
Interestingly, it has been shown that cognitive deﬁcits in
depression often remain when patients have been alleviated from
their psychopathological and neuropsychological symptoms (Rep-
permund et al., 2009, 2007), although their cortisol response to the
dexamethasone/corticotrophin-releasing hormone test has de-creased at remission (Reppermund et al., 2007). A dissociation be-
tween HPA system dysregulation and its impact on cognitive
function in depressed patients has therefore been postulated (Rep-
permund et al., 2007). This supports the idea that depressed pa-
tients’ cognitive deﬁcits are not due to an acute effect of an
increased HPA axis reactivity. It would therefore be interesting to
normalize the reactivity of the HPA axis reactivity of the HR mice
and examine if the cognitive deﬁcits remain. To this end, experi-
ments using a CRH-R1 antagonist are currently underway.
Although MD is more commonly associated with a hyper-active
HPA axis, MD is a heterogeneous disease, and one must consider
the different endophenotypes when attempting to model this dis-
order in animals. Indeed, the atypical subtype of depression is
associated with a hypoactive HPA axis and a more lethargic pheno-
type in comparison to melancholic or psychotic depression, which
is associated with a hyper-active HPA axis, agitation and hyper-
arousal (Angst et al., 2002; Antonijevic, 2006; Gold and Chrousos,
2002; Hasler et al., 2004; Nierenberg et al., 1998). It is furthermore
of vital importance to consider this when interpreting data of tests
attempting to model depression-like behavior in animals. The
forced swim test (FST) is a test classically used in rodents to screen
for antidepressive effects of substances (Cryan and Holmes, 2005),
it should however be stressed that the FST is not a test of depres-
sion, but rather gives an indication of the animal’s coping strategy
in an aversive situation. In this context, it is important to take into
account that different subtypes of depression would be character-
ized by different coping styles. A model of the spectrum of depres-
sion represented by a more agitated and hyperaroused state would
be expected to struggle more and ﬂoat less than the control group,
whereas a model of the atypical subtype of depression would here
be represented by a less active coping style, i.e. less struggling and
more ﬂoating compared to the control group. In accordance with
this, LR mice spent signiﬁcantly more time ﬂoating than the HR
mice, indicating a more passive coping style and increased behav-
ioral despair, whereas the HR mice exhibit decreased ﬂoating in
comparison to the IR and LR mice in both males and females
(Fig. 4A). These results are in concordance with previous ﬁndings
from studies of these mouse lines (Touma et al., 2008).
Examining the two pathological states, hyper-active or hypoac-
tive HPA axis in comparison to a control group of mice with a ‘‘nor-
mal” HPA axis response enables us to attempt to model both these
subtypes of MD and consider them separately in regard to end-
opheonotypes that differ between patients suffering from different
subtypes of MD, such as cognitive abilities and coping styles. The
LR mouse line therefore could model this passive phenotype in
association with a hypoactive HPA axis in similarity to atypical
depression, whereas the HR mice are characterized by a highly in-
creased HPA axis reactivity and a hyper-active coping style in sim-
ilarity to the melancholic subtype of depression. Furthermore,
memory deﬁcits have been associated with hypercortisolemia in
depressed patients (Belanoff et al., 2001; Bremner et al., 2004).
Most studies of cognitive deﬁcits in depression only differentiate
between unipolar and bipolar depression. However, when sub-
types of depression such as atypical and melancholic are consid-
ered, the cognitive deﬁcits are predominantly found in patients
suffering from the melancholic subtype of depression (Exner
et al., 2009), which also coincides with our ﬁndings that the HR
mice have cognitive deﬁcits. Previous studies of the stress reactiv-
ity mouse model have also demonstrated alterations in the emo-
tional behavior, neuroendocrine phenotype and sleep
architecture of the HR and LR mice revealing further similarities
to these different subtypes of depression (Touma et al., 2008,
2009).
Increased stress reactivity is presumably linked to cognitive
deﬁcits via up- or down-regulation of genes involved in learning
andmemory processes. BDNF is a prime candidate for investigation
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volved in learning and memory processes, and glucocorticoids reg-
ulate BDNF synthesis in the hippocampus (Chen et al., 1999; Egan
et al., 2003; Jacobsen and Mork, 2006; Korte et al., 1996; Lindholm
et al., 1994; Patterson et al., 1996). As predicted, HR mice of both
sexes had reduced amounts of BDNF content in the hippocampus
in comparison to the other lines (see Fig. 5). Furthermore, the cor-
ticosterone increase in response to the SRT was negatively corre-
lated to hippocampal BDNF across all three lines (see Fig. 6).
Albeit this is a relatively weak correlation and to prove a causal
relationship between the cognitive deﬁcits described in the HR
mice and the decreased BDNF levels further experiments would
have to be performed.
There are a myriad of ways that decreased BDNF levels in the
hippocampus could lead to cognitive deﬁcits. BDNF inﬂuences neu-
ronal excitability and has been implicated in synaptic plasticity
events such as LTP (Figurov et al., 1996; Patterson et al., 1996).
Moreover, BDNF increases neuronal survival (Kubo et al., 1995;
Sossin and Barker, 2007). The functional integrity of the neurons
may also be inﬂuenced by BDNF, as a single nucleotide polymor-
phism (SNP) in the BDNF gene, that leads to reduced intracellular
trafﬁcking and secretion of BDNF, has been reported to be associ-
ated with decreased hippocampal N-acetylaspartate levels, a mea-
sure of neuronal integrity in humans (Egan et al., 2003; Stern et al.,
2008). The mechanism by which BDNF inﬂuences cognitive abili-
ties in the stress reactivity mouse model, therefore, needs to be fur-
ther investigated.
BDNF has also been implicated in the pathophysiology of MD.
Depressed patients reportedly have lower plasma levels of BDNF,
which has been associated with memory impairment (Grassi-Oli-
veira et al., 2008; Lee et al., 2007; Monteleone et al., 2008). It is,
however, unclear whether there is an association between hippo-
campal BDNF levels and plasma BDNF levels in humans. A correla-
tion between serum and cortical BDNF has been reported in rats
(Karege et al., 2002). However, our ﬁndings indicate that there is
no such association, as the BDNF differences observed in the hippo-
campus are not found in the plasma of our three mouse lines. This
discrepancy could be explained by the multitude of factors able to
regulate BDNF transcription and release. A SNP affecting the levels
of BDNF would likely be found in both the neurons and platelets,
the main source of BDNF in the blood, leading to a similar expres-
sion of BDNF in the plasma and the brain. On the other hand, if
BDNF alterations were due to local hormone regulation, as we
are assuming is the case here, the plasma BDNF levels need not re-
ﬂect the brain BDNF levels. In MD patients, antidepressant treat-
ment has furthermore been shown to increase BDNF levels and is
suggested to be an important mechanism by which antidepres-
sants alleviate affective symptoms (Huang et al., 2008). The stress
reactivity mouse model could therefore be used to test new phar-
maceutical compounds’ abilities to increase BDNF levels and re-
verse affective and cognitive deﬁcits.
All the experiments in this study were conducted in male and
female mice revealing similar ﬁndings in both sexes. We would like
to emphasize the importance of also using female mice when
attempting to model symptoms of depression, as women have a
higher lifetime prevalence of depression than men, even though
the estrous cycle of females may complicate the interpretation of
the results. Due to the fact that monitoring the estrous cycle in
mice is relatively stressful, we assumed that the number of females
in estrus and proestrus would be counterbalanced across the three
lines as it is highly unlikely that their estrous cycles would be syn-
chronized as the females were single housed.
In this study we have investigated the cognitive abilities of mice
with both hyperreactive and hyporeactive HPA axes, as a dysregu-
lation of the HPA axis in either direction is relevant to depression.
The stress reactivity mouse model furthermore has the advantageover other mouse models of depression featuring stress or gluco-
corticoid exposure that it simulates the situation where the organ-
ism would be genetically predisposed to react in a detrimental way
to an environmental stressor. This allows us to investigate the pro-
gression of the symptoms of the disease as well as predisposing ge-
netic and environmental factors in our future research. The results
provided here, indicating a relationship between altered stress
reactivity, cognitive abilities, coping strategies, and hippocampal
BDNF levels are of signiﬁcant importance and demonstrate that
the stress reactivity mouse model can be utilized in the search
for putative new drug targets and the testing of such compounds,
as well as in furthering our knowledge of the underlying mecha-
nisms of the cognitive deﬁcits in MD.
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E-mail address: alanaknapman@hotmail.com (A. KIncreased stress reactivity has repeatedly been reported in patients suffering from psychiatric diseases
including schizophrenia and major depression. These disorders also have other symptoms in common,
such as cognitive deﬁcits and psychotic-like behavior. We have therefore investigated if increased stress
reactivity is associated with these phenotypic endpoints in an animal model of affective disorders. The
stress reactivity mouse model used in this study consists of three CD-1-derived mouse lines, that have
been selectively bred for high (HR), intermediate (IR) or low (LR) stress reactivity. Male mice from these
three breeding lines were subjected to a reversal learning task and latent inhibition (Li) was assessed
using a conditioned taste aversion paradigm. Furthermore, as the dopaminergic system is involved in
both Li and reversal learning, the dopamine 1 receptor (D1R), dopamine 2 receptor (D2R) and dopamine
transporter (DAT) mRNA expression levels were assessed in relevant brain areas of these animals. The
results demonstrate that HR mice show perseveration in the reversal learning task and have disrupted
Li. Furthermore, compared to LR mice, HR mice have decreased D2R mRNA levels in the ventral tegmental
area, as well as decreased D1R mRNA levels in the cingulate cortex, and an increased expression of D2R
mRNA in the nucleus accumbens. Taken together, these results demonstrate that the HR mice display
cognitive deﬁcits associated with psychotic-like behavior, similar to those observed in patients suffering
from schizophrenia and major depression and could be utilized in the search for better treatment strat-
egies for these symptoms of psychiatric disorders.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Although many treatment strategies are available, major
depression (MD) is not a fully treatable disorder (Holsboer & Ising,
2010; Wong & Licinio, 2001). This particularly applies to the symp-
toms in the cognitive realm that often subside when the affective
symptoms of the disease have successfully been treated (Repper-
mund, Ising, Lucae, & Zihl, 2009; Reppermund et al., 2007). Typical
antidepressants also lack the capacity to treat the psychotic symp-
toms of major MD (Holtzheimer & Nemeroff, 2006). It is therefore
of great importance to better understand the mechanisms underly-
ing these cognitive deﬁcits and psychotic symptoms and to explore
new potential targets for their treatment.
Drugs focusing on the dopaminergic system, such as atypical
antipsychotics, have shown great promise in treating depressed
patients who do not respond to typical antidepressants (Quintin
& Thomas, 2004). Atypical antipsychotics are believed to exert
their effect by increasing dopaminergic activity in the prefrontal
cortex (PFC) implicating the dopaminergic system in these symp-
toms (Ichikawa, Li, Dai, & Meltzer, 2002; Kuroki, Meltzer, & Ichi-ll rights reserved.
.
napman).kawa, 1999; Rollema, Lu, Schmidt, & Zorn, 1997). The
dopaminergic system subserves an optimal neuronal function in
the PFC (Cropley, Fujita, Innis, & Nathan, 2006), which plays a
key role in executive functioning tasks (Carpenter, Just, & Reichle,
2000; Petrides, 1994; Robbins & Arnsten, 2009). Fittingly, execu-
tive functioning tasks are the cognitive tasks that depressed pa-
tients and schizophrenic patients display the most deﬁcits in
(Austin, Mitchell, & Goodwin, 2001; Porter, Gallagher, Thompson,
& Young, 2003; Rabin, Sacco, & George, 2009; Reppermund et al.,
2007, 2009; Shirayama et al., 2009). Thus, it appears that psychotic
MD and schizophrenia (SZ) share certain symptoms and possibly
have similar underlying biological underpinnings causing these
symptoms. It was therefore our aim to study these symptoms as
phenotypic endpoint relevant to both disorders. The focus of this
study was the dopaminergic system and the behaviors likely to
be subserved by the dopaminergic system in the context of these
symptoms.
Dopamine plays a key role in the regulation of latent inhibition
(Li). Li is the phenomenon whereby pre-exposure to the to-be con-
ditioned stimulus retards the learning of subsequent pairing of the
unconditioned stimulus (US) and the conditioned stimulus (CS) (Lu-
bow, 1973). Disrupted Li is strongly associated with an increased
dopaminergic activity in the mesolimbic area (Lubow, 2005;
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1993) and is considered to be amodel of the inability to ignore irrel-
evant stimuli associated with schizotypy (Baruch, Hemsley, & Gray,
1988; Guterman, Josiassen, Bashore, Johnson, & Lubow, 1996; Ras-
cle et al., 2001; Schmidt-Hansen, Killcross, & Honey, 2009).
In addition to the affective and cognitive symptoms, dysregula-
tion of the hypothalamus–pituitary–adrenal (HPA) axis is com-
monly observed in patients suffering from MD (de Kloet, Joels, &
Holsboer, 2005; Holsboer, 2000; Holsboer & Ising, 2010; Ising
et al., 2005), but has also been reported in patients suffering from
SZ (Gallagher, Watson, Smith, Young, & Ferrier, 2007; Muck-Seler
et al., 2004; Ritsner et al., 2007; Ryan, Shariﬁ, Condren, & Thakore,
2004). An animal model of affective disorders, the ‘‘stress reactiv-
ity” mouse model, was therefore established using a selective
breeding approach to generate mice with high, intermediate or
low stress reactivity (Touma et al., 2008). Brieﬂy, a founder popu-
lation of CD-1 mice was subjected to a standardized stressor (15-
min restraint), and the increase of plasma corticosterone concen-
trations in response to this stressor was determined. Males and fe-
males with very high stress reactivity (HR) were then mated, as
were males and females with very low stress reactivity (LR). Their
offspring were tested for their stress reactivity in the same manner
and so forth for each generation to come (for details see (Touma
et al., 2008)). An intermediate reactivity (IR) line was additionally
established to serve as a control group with the same inbreeding
status as the other two lines. The IR mice present a corticosterone
response similar to the mean of the founder population of CD-1
mice (Touma et al., 2008). In this study, these three mouse lines
have been utilized to investigate the effect of a hyperactive vs. hyp-
oactive HPA axis reactivity on the dopaminergic system as well as
behaviors subserved by the dopaminergic system that are relevant
to the psychotic and cognitive deﬁcits observed in MD and SZ. Ulti-
mately, we aim to provide a mouse model for cognitive deﬁcits and
psychotic symptoms that could be utilized in the search for better
treatment options for these symptoms.
To this end, mice from the stress reactivity model were sub-
jected to a reversal learning task, and Li was assessed in a condi-
tioned taste aversion paradigm. The brains of these animals were
subsequently analyzed via in situ hybridization to measure dopa-
mine 1 receptor (D1R), dopamine receptor 2 (D2R) and dopamine
transporter (DAT) mRNA levels in relevant brain areas.
2. Methods
2.1. Subjects
A total of 48 male mice were used in these experiments. The
mice originated from the 11th generation of the stress reactivity
mouse model. This mouse model consists of three CD-1-derived
mouse lines, selectively bred for high (HR), intermediate (IR) or
low (LR) stress reactivity, respectively (Touma et al., 2008). Stress
reactivity was determined by the method described below. From
each breeding line, HR, IR, and LR, 16 male mice were selected
according to their plasma corticosterone increase in the SRT. With-
in each breeding line, two independent sub-lines, A and B, exist.
These sub-lines were never interbred and serve as a replication
of the breeding protocol conducted in parallel. The 16 mice of each
group comprised of 8 mice from each sub-line. Two weeks prior to
the onset of behavioral testing all animals were single housed un-
der standard laboratory conditions in transparent polycarbonate
cages (standard macrolon cages type II, 38  22  15 cm) with
food and water available ad libitum. Testing and housing rooms
were maintained on a 12:12 h light–dark cycle with a constant
temperature and humidity of 22 ± 1 C and 55 ± 10%, respectively.
All behavioral tests and hormone measurements were conducted
during the ﬁrst 4 h of the light phase when the animals were stillrelatively active and corticosterone levels are at their circadian
trough. The presented work complies with current regulations cov-
ering animal experimentation in Germany and the EU (European
Communities Council Directive 86/609/EEC). All experiments were
announced to the appropriate local authority and were approved
by the ‘Animal Welfare Ofﬁcer’ of the Max Planck Institute of
Psychiatry.
2.2. Stress reactivity test
All the mice used in these experiments were tested in the
‘‘stress reactivity test” (SRT) at the age of approximately eight
weeks. The test comprises of an initial blood sample collected from
a small incision in the ventral tail vessel, followed by 15 min of re-
straint stress and ﬁnally a reaction blood sample (for details see
Touma et al., 2008), collected from a second incision in the ventral
tail vessel immediately after the restraint stressor. Corticosterone
levels in the blood plasma were analyzed as described below.
The test was performed during the ﬁrst hours of the light phase
when corticosterone levels are at their trough level.
2.3. Plasma corticosterone measurements
A radioimmunoassay (RIA) kit (MP Biomedicals, Solon, Ohio,
USA) was used with a slight modiﬁcation to the manufacturer’s
instructions to determine corticosterone levels in the plasma sam-
ples. Only half of the recommended volumes were used for all
components to increase the amount of samples that could be ana-
lyzed per kit. From the initial sample, 10 ll of plasma was diluted
1:13.5, and for the reaction sample, 10 ll of plasma was diluted
1:100. The difference in dilution ensures that the samples are with-
in the linear part of the standard curve. Inter- and intra-assay coef-
ﬁcients of variation were both below 10%.
2.4. Reversal learning task
Reversal learning is a useful task to test the functional integrity
of the PFC in patients and animal models of psychiatric diseases
(Clark, Cools, & Robbins, 2004).The mice were tested in the reversal
learning task at the age of approximately 16 weeks. A T-maze with
three 50 cm long arms made out of Plexiglas, mounted on a table
with the height of 50 cm was used for this test. The arms could
individually be opened or closed via transparent Plexiglas pulley
doors. The walls of the start arm were covered in black paper with
diagonal white stripes; one of the goal arm’s walls was white and
the other black. At the end of one of the goal arms an escape tunnel
made of chicken wire with a diameter of 5 cm was present leading
back to the mouse’s home cage which was placed on the ﬂoor to
ensure that the mouse could neither smell nor see its cage from
the center of the maze. At the end of the other arm a ‘dummy’ tun-
nel was present that consisted of an identical chicken wire tunnel
with a dead end after 20 cm to ensure that the two arms looked
identical from the center of the maze where the mouse made its
choice of which arm to enter. The mouse was placed in a Plexiglas
start box with a trap door. The start box was placed in the begin-
ning of the start arm and the trap door was opened. When the
mouse reached the end of the start arm and entered the center
zone the pulley door to the start armwas closed so the mouse must
choose one of the goal arms. When the mouse had selected one of
the goal arms the door to that armwas closed. If the mouse entered
the correct arm it was allowed to proceed to its home cage via the
escape tunnel. If the incorrect arm was selected the mouse re-
ceived a mildly aversive air-puff and was left in the arm for 30 s,
and subsequently returned to its home cage. The mice were trained
to ﬁnd their home cage by turning left or right and selecting the
correct goal arm. They were tested in batches of three (one mouse
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mately 5 min. Which arm was the goal arm was counterbalanced
across the groups. When the mouse had achieved to select the cor-
rect arm 8 out of 10 times, it had reached the learning criterion and
was left undisturbed until the next day. As the inter-trial interval
was comparatively short the mice were retested 24 h later to en-
sure that they still recalled where the correct arm was and to see
if the groups differed in memory retention, as such differences
would confound the subsequent reversal task. On the third day,
24 h after the retention trial, the goal arm with the escape tunnel
was moved to the opposite arm and the mouse had to learn the
new position of the arm. The learning criterion of eight out of
ten correct trials was again applied. The number of trial to reach
the learning criterion for each stage of the test (acquisition, retrie-
val and reversal) was recorded and subsequently used to statisti-
cally compare the three breeding lines. Twelve animals per line
were tested in this paradigm. If an animal failed to reach the learn-
ing criterion by 30 trials or needed more trials to reach the learning
criterion the second day (the retrieval phase) it was excluded from
the analysis at all stages of the test. The ﬁnal number of animals (N)
for each group is presented along with the outcome of statistical
analysis in Section 3.
2.5. Latent inhibition
Latent inhibition (Li) is the phenomenon whereby pre-exposure
to the to-be conditioned stimulus retards the learning of subse-
quent pairing of the unconditioned stimulus (US) and the condi-
tioned stimulus (CS) (Lubow, 1973). Li was assessed when the
animals were approximately 21 weeks old. The mice were habitu-
ated to water deprivation over a period of 4 days to reduce the
stress of water deprivation. During this period they were given
the opportunity to drink from either of two water bottles, one
placed on the left and one placed on the right side of the cage-
lid, for 30 min twice daily with an interval of 4 h. By so means,
we could deduce if any mouse had a preference for the right or
the left bottle. Custom made non-drip water bottles were used
and the bottles were weighed before and after each drinking ses-
sion with a precision of 0.1 g to measure the amount of ﬂuid con-
sumed. On the ﬁfth day, the pre-exposure day, the three groups of
mice consisting of 16 HR, IR and LR mice, respectively, were split
into two groups each, leading to six groups of eight mice. One
group from each line, the pre-exposed (PE) group, was given a
10% sucrose solution in both bottles during the ﬁrst 30-min drink-
ing session. The other group, the non pre-exposed group (No PE),
was given tap water as during the habituation period. On day six
of the experiment, the conditioning day, all animals were given su-
crose solution to drink, the conditioned stimulus (CS), and were in-
jected with a volume of 2% of the body weight 0.25 M lithium
chloride (LiCl) dissolved in 0.9% sodium chloride (NaCl) solution
intraperitoneally, ﬁve minutes after the drinking session in order
to induce nausea, the unconditioned stimulus (US). On the second
drinking session of the day, all mice were again given tap water in
both bottles. On day seven of the experiment, the test day, all ani-
mals were given the choice between tap water and sucrose solu-
tion. The stronger the CS–US pairing the less sucrose solution an
animal will drink. A weaker CS–US pairing is to be expected in
the PE group compared to the No PE group if the animals exhibit
latent inhibition. In order to make this comparison, a ratio of
how much water compared to sucrose was consumed was calcu-
lated ((water consumption – sucrose solution consumption)/total
volume consumed) for each group. This ratio or discrimination in-
dex was then used to statistically compare the PE and No PE group
within each breeding line. If an animal showed a side preference
during the habituation period the bottle containing water was
placed on that side in the PE group and the sucrose was placedon that side in the No PE group, so that any bias due to a side pref-
erence would be in an unfavorable direction making it unlikely to
produce a false positive result due to side preferences of the
animals.
2.6. Brain collection
The experimental animals were left undisturbed for three
weeks after all behavioral tests were completed before the brain
collection took place. The animals were approximately 25 weeks
old at this time. Animals were brieﬂy anaesthetized with isoﬂurane
and then rapidly decapitated. The brain was removed from the
scull and immediately frozen in n-methylbutane cooled on dry
ice, within three minutes of touching the animals’ cage, to ensure
that subsequent mRNA measurements reﬂected baseline levels.
The brains were stored at 80 C until further processing for
in situ hybridization.
2.7. In situ hybridization histochemistry
Brains were cut in 14 lm thick slices using a MICROM HM 560
cryostat (MICROM International GmbH, Walldorf, Germany) and
freeze mounted onto glass slides. The cut brains were stored at
20 C and further processed approximately one week later. The
details of the in situ hybridization procedure are described else-
where (Wigger et al., 2004). In brief, sections were ﬁxed in 4% para-
formaldehyde, washed in 10 ( PBS, followed by acetic anhydride
and passed through a series of ethanol in increasingly high concen-
tration from 65% to 100%, then brieﬂy bathed in chloroform and
then again in 100% ethanol. After the slides had been air dried for
approximately 1 h, 10 ll of hybridization mix was applied to each
slide, including a 35S radio-labeled probe calculated to 1 million
counts of radioactivity per slide. The probes used were designed
to recognize the following D1 dopamine receptor (D1R) (Dearry
et al., 1990; Gross et al., 2003), D2 dopamine receptor (D2R, mix
of three oligonucleotides) (Dal Toso et al., 1989; Gross et al.,
2003), and dopamine transporter (DAT) (Jaber et al., 1999). The
slides were covered with cover-slips and sealed into a hybridiza-
tion chamber, which was incubated at 45 C over night (18–22 h).
The cover-slips were then removed in 1 SSC buffer (diluted from
20 SSC; 175 g NaCl, 88 g tri-Na–Citrate dehydrate) and the slides
were subsequently bathed in 1 SSC 4 times 15 min at 45 C,
allowing the slides to come to room temperature during the last
bath. Finally, the slides were passed through a graded series of eth-
anol yet again (65%, 95% and 100%) and left to air dry for several
hours before they were placed on radiation-sensitive ﬁlms (Kodak
BioMax, Eastman Kodak Co., Rochester, New York, USA) for 4 days.
Films were subsequently scanned and the signal intensity was
estimated for each region of interest; nucleus accumbens (NAc),
caudate–putamen (CP), ventral tegmental area (VTA), and cingu-
late cortex (CgCtx), using ImageJ software (National Institute of
Health). For each region, two to four brain sections were analyzed.
In addition, for each brain slice, a background signal consisting of a
nearby region without speciﬁc labeling was estimated and sub-
tracted from the hybridization signal of each region of interest. If
there was not more than one quantiﬁable slice from an animal it
was excluded from the analysis. The ﬁnal number of animals (N)
included in the statistical analysis is presented together with the
statistics in the results section.
2.8. Statistical analysis
The data was exclusively analyzed using non-parametric statis-
tics as a normal distribution and variance homogeneity of the data
could not always be assumed. The Kruskal–Wallis H-test (KWH-
test) was used to compare more than two independent samples.
Fig. 1. Reversal learning task in mice selectively bred for high (HR), intermediate
(IR) and low (LR) stress reactivity. The number of trials necessary to reach the
learning criterion of 8/10 correct trials for each stage of the test, acquisition,
retrieval and reversal, are given as box plots showing medians (lines in the boxes),
25% and 75% percentiles (boxes). The 10% percentile and 90% percentile are
indicated by the whiskers. Each phase of the test was statistically analyzed
separately using the KWH-test (results given above the line encompassing the
perimeter of all three box plots) followed by post-hoc MWU-tests (results given
above the line connecting the middle of the two box plots being compared) where
appropriate (Bf corrected p < 0.05, p < 0.1 T).
Fig. 2. Latent inhibition in a conditioned taste aversion paradigm in mice
selectively bred for high (HR), intermediate (IR) and low (LR) stress reactivity.
Within each line the discrimination ratio of water to sucrose solution of animals
pre-exposed (PE) to the ‘‘to be conditioned stimulus” (sucrose solution) is compared
to a nonpre-exposed (No PE) group (W-test, p < 0.01, p < 0.05). Data are depicted
as box plots showing medians (lines in the boxes), 25% and 75% percentiles (boxes).
The 10% percentile and 90% percentile are indicated by the whiskers.
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performed using the MannWhitney U-test (MWU-test). Sequential
Bonferroni (Bf) correction was applied to correct for multiple test-
ing, when appropriate. In order to compare two dependent sam-
ples the Wilcoxon test (W-test) was applied. The statistical
analysis was performed using SPSS software (SPSS Inc., Chicago,
IL, USA). Two tailed p-values are reported in all cases and statistical
signiﬁcance was set to p < 0.05. p-values between 0.05 and 0.1
were reported as trends.
3. Results
3.1. Stress reactivity test
The differences in the restraint stress-induced corticosterone
increase were highly signiﬁcant between the three breeding lines
(KWH-test: HR: N = 16, IR: N = 16, LR: N = 16, H = 41.80, df = 2,
p < 0.001; post-hoc MWU-tests: all U = 0, all p < 0.001), with HR
mice having the highest increase (mean ± SEM: 400 ± 12.5 ng/ml),
LR mice the lowest (mean ± SEM: 52.3 ± 3.0 ng/ml) and IR mice
being intermediate (mean ± SEM: 176.7 ± 3.5 ng/ml). These ﬁnd-
ings are in accordance with previous generations of the stress reac-
tivity mouse model (Touma et al., 2008, 2009). Furthermore, the
three lines differed in their corticosterone levels in the initial blood
sample taken in the SRT, with the highest levels found in the HR
mice and the lowest levels in the LR mice (mean ± SEM:
HR: 8.4 ± 21.9 ng/ml, IR: 3.8 ± 1.1 ng/ml, LR: 1.1 ± 0.1 ng/ml). These
effects were statistically signiﬁcant (KWH-test: HR: N = 16, IR:
N = 16, LR: N = 16, H = 19.86, df = 2, p < 0.001; post-hocMWU-tests:
U = 25–92, HR vs. IR: p > 0.1, HR vs. LR: p < 0.001, IR vs. LR:
p < 0.001). This is in accordance with ﬁndings in previous genera-
tions and can be attributed to the increased trough levels of the cir-
cadian rhythm of glucocorticoid secretion observed in HR mice
(Touma et al., 2008, 2009).
3.2. Reversal learning task
Mice from the three breeding lines did not signiﬁcantly differ in
their acquisition of the task (KWH-test: HR: N = 9, IR: N = 9, LR:
N = 8, H = 0.01, df = 2, p > 0.1; Fig. 1), nor did they differ in their
retention of the task (KWH-test: HR: N = 9, IR: N = 9, LR: N = 8,
H = 4.06, df = 2, p > 0.1; Fig. 1) on the subsequent day. However, in
the reversal phase of the test, on the third day, HR mice needed sig-
niﬁcantly more trials to reach the learning criterion than LR mice,
and IR mice tended towards needing more trials to reach the learn-
ing criterion than LRmice (KWH-test: HR: N = 9, IR: N = 9, LR: N = 8,
H = 6.19, df = 2, p < 0.05; post-hocMWU-tests: U = 10–38, HR vs. LR:
p < 0.05; HR vs. IR: p > 0.1; IR vs. LR: p < 0.1; Fig. 1).
3.3. Latent inhibition
In IR and LR mice, the discrimination ratio ((water consumption
– sucrose solution consumption)/total volume consumed) of the PE
group was signiﬁcantly higher in the nonpre-exposed group than
the pre-exposed group (MWU-test: IR: both N = 8, U = 7, p < 0.01;
LR: both N = 8, U = 12, p < 0.05; Fig. 2), indicating a higher prefer-
ence towards water in the non pre-exposed group, which is to be
expected if animals exhibit Li. However, in HR mice, the discrimi-
nation ratio between PE and No PE groups did not signiﬁcantly dif-
fer (MWU-test: both N = 8, U = 19, p > 0.1; Fig. 2), indicating that
HR mice display disrupted Li.
3.4. In situ hybridization
All probes used for in situ hybridization showed a speciﬁc bind-
ing with a low background signal intensity (see Fig. 3). HR micehad decreased levels of D1R mRNA in the CgCtx compared to LR
mice (MWU-tests: HR: N = 11, LR: N = 10, U = 23, p < 0.05;
Fig. 4a). However, there were no signiﬁcant differences between
the HR and LR mice in D1R mRNA levels in the NAc or CP
(MWU-test: NAc: HR: N = 11, LR: N = 10, U = 45, p > 0.1; CP: HR:
N = 11, LR: N = 10, U = 41, p > 0.1 Fig. 4b and c). Furthermore, no
signiﬁcant differences between HR and LR mice were detected in
the expression of D2R mRNA in the cingulate cortex (MWU-tests:
HR: N = 16, LR: N = 16, U = 133, p > 0.1; Fig. 5a). HR mice did how-
ever have increased levels of D2R mRNA in the NAc compared to LR
mice (MWU-tests: HR: N = 14, LR: N = 15, U = 56, p < 0.05; Fig. 5b),
as well as a tendency towards increased levels of D2R mRNA in the
Fig. 3. Representative brain sections of high (HR) and low (LR) stress reactive mice
hybridized with dopamine 1 receptor (D1R), dopamine 2 receptor (D2R) or
dopamine transporter (DAT) oligoprobes, showing the striatum and cingulate
cortex (a) and the ventral tegmental area (b).
Fig. 4. Dopamine receptor 1 (D1R) mRNA levels in the (a) cingulate cortex (CgCtx),
(b) nucleus accumbens (NAc), and (c) caudate–putamen (CP) of mice selectively
bred for high (HR) and low (LR) stress reactivity, respectively. Data from HR and LR
mice are depicted as box plots showing medians (lines in the boxes), 25% and 75%
percentiles (boxes). The 10% percentile and 90% percentile are indicated by the
whiskers. As a reference the mean ± standard error of the mean of the intermediate
(IR) stress reactive mice is depicted as the area between the horizontal lines. HR and
LR mice were compared statistically using the MWU-test (p < 0.05).
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the contrary, HR mice had signiﬁcantly decreased D2R mRNA lev-
els in the VTA compared to LR mice (MWU-test: HR: N = 15, LR:
N = 10, U = 36, p < 0.05; Fig. 4d). DAT mRNA levels in the VTA did
not signiﬁcantly differ between HR and LR mice (MWU-test: HR:
N = 16, LR: N = 9, U = 54, p > 0.1; Supplementary Fig. 1). Further-
more, if the results of the two independent sub-lines of HR and
LR mice, respectively, were regarded separately, the observed
alterations of the DA system were similar in both sub-lines (see
Supplementary Figs. 2–4). This indicates that the alterations of
the DA system are indeed associated with the stress reactivity phe-
notype and not brought about by effects of genetic drift.
4. Discussion
The aim of the present study was to examine if mice with in-
creased stress reactivity display behaviors associated with cogni-
tive and psychotic features of major depression and
schizophrenia. Furthermore, the dopaminergic system of these
mice was investigated in brain areas relevant to these behaviors.
The experiments reported here demonstrate that mice selected
for high stress reactivity have deﬁcits in reversal learning and dis-
rupted Li, along with congruent alterations in the expression of
D1Rs and D2Rs in relevant brain areas. Apart from the brain areas
we have focused on here, the PFC, NAc and VTA, the hippocampus
has also been implicated in Li (Weiner & Feldon, 1997). Our previ-
ous studies have shown that HR mice have deﬁcits in hippocam-
pus-dependent cognitive tests (Knapman et al., 2009), such asthe novel object recognition test and the Y-maze test. In addition,
tests of anxiety and depression-like behavior have previously been
performed on the stress reactivity mouse model, including ele-
vated plus-maze and forced swimming (Touma et al., 2008). These
tests indicate that the three mouse lines do not differ in measures
of anxiety, however, there are robust differences in their coping
strategy in other tests such as the forced swim test (Knapman
et al., 2009; Touma et al., 2008). These ﬁndings along with reported
differences in sleep architecture (Touma et al., 2009) and neuroen-
docrine measures have served to establish the stress reactivity
moue model as a model of affective disorders.
Patients suffering from major depression and schizophrenia
typically show deﬁcits in PFC-dependent tasks, such as the Wis-
consin Card sorting test (Rabin et al., 2009; Shirayama et al.,
2009). Interestingly, these patients also often exhibit an increased
HPA axis activity when subjected to the dexamethasone/cortico-
tropin-releasing hormone test (Gallagher et al., 2007; Holsboer,
Liebl, & Hofschuster, 1982; Holsboer, von Bardeleben, Wiedemann,
Muller, & Stalla, 1987; Ising et al., 2005; Muck-Seler et al., 2004;
Fig. 5. Dopamine receptor 2 (D2R) mRNA levels in the (a) cingulate cortex (CgCtx),
(b) nucleus accumbens (NAc), (c) caudate–putamen (CP), and (d) ventral tegmental
area (VTA) of high (HR) and low (LR) stress reactive mice. Data from HR and LR mice
are depicted as box plots showing medians (lines in the boxes), 25% and 75%
percentiles (boxes). The 10% percentile and 90% percentile are indicated by the
whiskers. As a reference the mean ± standard error of the mean of the intermediate
(IR) stress reactive mice is depicted as the area between the horizontal lines. HR and
LR mice were compared statistically using the MWU-test (p < 0.05, p < 0.1T).
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deﬁcits in PFC-dependent tasks and stress reactivity, also shown
in our mouse model, may be brought about by increased exposure
of the PFC to glucocorticoids, as this region has an abundant
expression of glucocorticoid receptors (Ahima & Harlan, 1990; Ahi-
ma, Krozowski, & Harlan, 1991; Aronsson et al., 1988). In addition,it is possible that the decreased amounts of D1R in the cingulate
cortex of HR mice play a role in the decreased performance in
the reversal learning task, as the dopaminergic system is known
to subserve an optimal functioning of the PFC (Cropley et al.,
2006). It is likely that the alterations of the dopaminergic system
are a consequence of the genetically driven increased stress reac-
tivity phenotype, rather than being due to the accidental selection
of a genetic drift-related genotype unrelated to stress reactivity, as
these changes in the dopaminergic system are observed in both of
the two independent sub-lines of HR mice (see Supplementary
Figs. 2-4). The VTA has also been implicated in learning processes
where the outcome is not as predicted. The spiking activity of DA
neurons in the VTA is higher in response to an unexpected reward
and lower in response to a negative prediction error (Roesch, Calu,
& Schoenbaum, 2007). Interestingly, HR mice have a reduced
expression of D2R mRNA in the VTA compared to LR mice. Thus,
one could speculate that the VTA of the HR mice is not correctly
signaling prediction errors, which in turn would lead to difﬁculty
in learning tasks where the outcome is not as predicted, such as
the reversal learning task performed in this study. A lack of differ-
ences in learning and memory retention between the three lines in
this phase of the test may appear to be contradictory to the previ-
ously published data demonstrating differences in the novel object
recognition test and the Y-maze test. However, the reversal learn-
ing task was speciﬁcally designed to have a low degree of difﬁculty
in the acquisition and retention phase as any difference between
the lines at this phase of the test would confound the reversal
phase of the test.
The HR mice furthermore display disrupted Li, which is also
commonly observed in patients suffering from psychotic disorders
(Gray, Pickering, Hemsley, Dawling, & Gray, 1992; Gray, Pilowsky,
Gray, & Kerwin, 1995; Lubow, Kaplan, Abramovich, Rudnick, &
Laor, 2000; Rascle et al., 2001). Li is a measure of selective atten-
tion, often used to model the cognitive deﬁcits associated with psy-
chotic behavior in animal models and patients. An increase in
mesolimbic DA has been strongly implicated in disrupted Li (Solo-
mon & Staton, 1982; Weiner, 1990; Young et al., 1993), and pa-
tients suffering from schizophrenia reportedly have an increased
DA activity in the mesolimbic area along with increased amounts
of D2Rs in the striatum (Abi-Dargham, 2003; Alves Fda, Figee,
Vamelsvoort, Veltman, & de Haan, 2008; Carlsson & Lindqvist,
1963; Carlsson, Waters, Waters, & Carlsson, 2000; Mawlawi
et al., 2001). Our ﬁndings of an increased expression of D2R mRNA
in the HR mice, along with disrupted Li, thus demonstrate that the
HR mice show similarities to psychotic features of schizophrenia
and major depression.
Disrupted Li and perseveration in a reversal learning task are in
a sense non- congruent, as disrupted Li implies that the animal is
switching its behavior, when it should not, and in the reversal
learning task it is not switching its behavior, when it should. How-
ever, from a neurobiological perspective, the situation of disrupted
Li and reversal learning deﬁcits may occur in the same individual,
as the mechanisms behind the switching behavior in Li and the
pathways involved in reversal learning are not believed to be iden-
tical (Clark et al., 2004; Floresco, Zhang, & Enomoto, 2009; Weiner,
1990). Interestingly, the ﬁnal outcome of the response of the HR
mice in the two behavioral tests used in this study is similar in that
both perseveration and disrupted Li imply a lack of a capacity to
modify a behavioral response in accordance to a new response con-
tingency. This can be extrapolated to predict an inability to adapt
to new and stressful situations in a way that is beneﬁcial to the
organism, thus causing a prolonged and more severe stress reac-
tion to these situations. In theory, this could be a vicious circle,
with increased stress reactivity leading to alterations in the brain,
that render the organism incapable of adapting to a changing envi-
ronment, which in turn would lead to more stress, that could
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behavioral modiﬁcations to a changing environment.
Rodent models of affective disorders where mice are subjected
to stress, such as the chronic mild stress paradigm in mice and rats,
or maternal deprivation in rats, have a behavioral phenotype sim-
ilar to what we have observed in HR mice, and similar alterations
of the DA system have been reported (Bielajew, Konkle, & Merali,
2002; Ellenbroek & Cools, 2002; Rentesi, Antoniou, Marselos, &
Konstandi, 2009; Willner, 2005). Studies using the chronic mild
stress model of major depression, which is also known to increase
HPA axis reactivity in rats (Bielajew et al., 2002), have found both
increased and decreased D2R binding in the striatum (Willner,
2005). Interestingly, D2R binding was found to be increased in
mice/rats with an ‘‘anomalous” proﬁle and decreased in mice with
a ‘‘depressive” proﬁle (Willner, 2005). One of the anomalous
behavioral effects reported was a decreased amount of time ﬂoat-
ing in the forced swim test, which has also previously been re-
ported in the HR mice (Knapman et al., 2009; Touma et al.,
2008). The maternal deprivation model of affective disorders has
also been conﬁrmed to show cognitive deﬁcits related to psychotic
behavior (Ellenbroek & Cools, 2002), increased D2R protein levels
in the striatum (Rentesi et al., 2009), as well an increased HPA axis
reactivity in response to a stressor in rats (Aisa, Tordera, Lasheras,
Del Rio, & Ramirez, 2007).
The advantage of our mouse model is that the HR mice simulate
a situation where the organism is genetically predisposed to hy-
per-react to stressors, which is a more natural approach than the
chronic mild stress paradigm or maternal deprivation paradigms.
Interestingly, we have demonstrated here that the HR mice show
behavioral and anatomical differences that are similar to the alter-
ations described above to be observed in the chronic mild stress
paradigm and maternal deprivation models, although the HR mice
have not repeatedly been subjected to a stressor. We hypothesize
that the increase in glucocorticoid exposure in response to the
events that mice are normally subjected to, such as cage changing,
unavoidable noise in the animal house or agonistic interactions
with cage mates, is sufﬁcient to induce the observed changes.
The possibility to use a top down approach, starting with a known
phenotype and studying the genotypic and molecular differences
between HR and LR mice, is yet another advantage of the model.
Furthermore, the majority of studies using the chronic mild stress
paradigm or maternal deprivation use rats. Thus, the stress reactiv-
ity mouse model has the further advantage that it is based on mice,
as the mouse genome is better annotated than the rat genome,
which is advantageous when searching for genetic correlates of
behavioral phenotypes.
Although we have not demonstrated a causal link between
stress reactivity, the alterations to the DA system and the behav-
ioral phenotype observed, these behavioral differences and altera-
tions of the dopaminergic system are not likely to be due to genetic
drift, i.e. accidentally selecting for genes unrelated to increased
stress reactivity in the HR mice, as both sub-lines of HR mice dis-
play a similar phenotype. Furthermore, it has repeatedly been
demonstrated that alterations of the DA system in concordance
with our ﬁndings are the underlying mechanism of disrupted Li
(Lubow, 2005; Solomon & Staton, 1982; Weiner, 1990; Young
et al., 1993). In addition, D2Rs in the NAc and VTA have been
strongly implicated in the expression of fear following fear condi-
tioning, another form of learning involving conditioned associa-
tions (de Oliveira, Reimer, & Brandao, 2006, 2009; Martinez,
Oliveira, Macedo, Molina, & Brandao, 2008). This strongly impli-
cates the alterations to the DA system of the HR mice in their
behavioral deﬁcits.
In summary, the experiments presented here have shown for
the ﬁrst time that a genetic predisposition for increased stress
reactivity, without speciﬁcally subjecting the animal to repeatedstressors prior to testing, is sufﬁcient to alter the DA system. In
addition, the HR mice display concomitant deﬁcits in behaviors
subserved by the DA system, such as Li and reversal learning. These
ﬁndings are important in understanding the relationship between
HPA axis hyperactivity, cognitive deﬁcits and psychotic symptoms
in major depression and schizophrenia and demonstrate that the
HR mice can be used to explore new targets for treating these
disorders.Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.nlm.2010.04.010.References
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ABSTRACT 
Patients suffering form major depression (MD) have repeatedly been reported to have a dysregulated 
hypothalamus-pituitary-adrenal (HPA) axis along with deficits in cognitive processes, which are related to 
hippocampal and prefrontal cortex (PFC) function. Whether these symptoms are causally related still remains 
unclear. In this study we have utilized three lines of mice selectively bred for high (HR), intermediate (IR), or 
low (LR) stress reactivity to probe the behavioral, functional, morphological and molecular consequences of an 
increased HPA axis reactivity on the hippocampus and PFC. We assessed their perfromance in hippocampus- 
and PFC-dependent cognitive tasks and determined the morphology, basal activity, and neuronal integrity of the 
hippocampus and prefrontal cortex. using in-vivo manganese-enhanced magnetic resonance imaging (MEMRI) 
and proton magnetic resonance spectroscopy (1H-MRS). Additionally, the hippocampal proteome of HR and 
LR mice was compared. We found deficits in performance of hippocampus- and PFC-dependent tests in HR 
mice which could be related to decreased N-acetylaspartate (NAA) levels, a marker of neuronal integrity, in the 
right dorsal hippocampus and prefrontal cortex. Furthermore, the basal activity of the hippocampus as assessed 
by MEMRI was reduced in HR mice; however, the three lines did not differ in hippocampal volume. The 
majority of the proteins that were found to be differentially expressed in HR and LR mice were involved in 
energy metabolism, suggesting that mitochondrial dysfunction may be the underlying cause of the observed 
behavioral deficits and alterations in neuronal integrity and function. 
 
 
INTRODUCTION 
Increased stress reactivity has repeatedly been 
demonstrated in patients suffering from major 
depression (MD) and schizophrenia (SZ) 
(Holsboer, 2000; Muck-Seler et al., 2004; Ryan et 
al., 2004; de Kloet et al., 2005; Ising et al., 2005; 
Gallagher et al., 2007; Ritsner et al., 2007; 
Holsboer and Ising, 2010). It has been proposed 
that an excessive amount of circulating 
corticosteroids would be detrimental for specific 
brain areas, namely the hippocampus and 
prefrontal cortex (PFC) (Sapolsky et al., 1990; 
Swaab et al., 2005; Zhu et al., 2007; Radley et al., 
2008). These brain areas are important in cognitive 
processes, such as learning, memory and executive 
functioning (Scoville and Milner, 1957; Petrides, 
1994; Carpenter et al., 2000; Eichenbaum, 2000; 
Robbins and Arnsten, 2009). Interestingly, deficits 
in these cognitive processes have repeatedly been 
demonstrated in patients suffering from MD and 
SZ (Austin et al., 2001; Porter et al., 2003; Rabin et 
al., 2009; Shirayama et al., 2009) and have been 
linked to an increased hypothalamus-pituitary-
adrenal (HPA) axis activity (Belanoff et al., 2001; 
Bremner et al., 2004).  
We have here made use of a previously 
established mouse model of affective disorders, the 
stress reactivity (SR) mouse model, which consists 
of three CD-1-derived breeding lines that are 
selectively bred for high (HR), intermediate (IR), 
or low (LR) reactivity of the HPA axis (Touma et 
al., 2008). It has previously been demonstrated that 
the SR mouse model is a valid model of MD and 
that the HR mice have cognitive deficits associated 
with depression and psychotic behavior (Touma et 
al., 2008; Knapman et al., 2009; Touma et al., 
2009; Knapman et al., in press-a).  
In-vivo magnetic resonance (MR) 
spectroscopy was used to assess the levels of N-
acetylaspartate (NAA) in the dorsal hippocampus 
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and PFC of the three breeding lines. NAA, which 
gives rise to a prominent signal in 1H-MRS of the 
brain, is a metabolite exclusively found in neurons 
(Birken and Oldendorf, 1989; Moffett et al., 1991). 
Since NAA signal amplitude is decreased in 
association with both cellular dysfunction and 
neuronal loss (Demougeot et al., 2001), NAA is 
considered to be a marker of neuronal integrity. 
Patients suffering from MD and SZ have shown 
decreased values of the NAA/Creatin (Cre) ratio in 
the hippocampus and PFC (Buckley et al., 1994; 
Bertolino et al., 1998; Gonul et al., 2006). Since 
these brain areas are also likely to be affected by 
glucocorticoid exposure, we additionally 
investigated the volume and functional activity of 
brain areas likely to be affected by glucocorticoid 
exposure, namely the hippocampus and PFC, in the 
SR mouse model, using manganese enhanced 
magnetic resonance imaging (MEMRI). 
Manganese ions enters the cells through voltage 
gated calcium channels during depolarization, in an 
activity dependent manner. Their paramagnetic 
properties lead to a positive contrast enhancement 
in T1-weighted magnetic resonance images 
(Mendonca-Dias et al., 1983; Simpson et al., 
1995). Manganese ions accumulate in the brain of 
freely behaving mice over an extended period of 
time, thus leading to pronounced signal 
enhancement in activated brain regions, which can 
finally be read-out under anaesthesia in the MR-
scanner. These properties therefore allow an in-
vivo assessment of neuronal activity. As 
intraperitoneally applied manganese especially 
enlightens the hippocampal formation, MEMRI 
also enables a semi-automatic determination of the 
hippocampal volume. Furthermore, the cognitive 
abilities of the SR mice have been assessed using 
specific hippocampus- and PFC-dependent tests. In 
addition, the hippocampal proteome of HR and LR 
mice was compared, in order to probe the 
underlying mechanism of altered hippocampal 
function.  
  
 
METHODS 
ANIMALS AND HOUSING CONDITIONS 
A total of 92 adult male mice from the SR mouse 
model were used in these experiments. The SR 
mouse model consists of three independent CD-1-
derived mouse lines. These three lines are 
selectively bred for high (HR), intermediate (IR) 
and low (LR) stress reactivity, respectively (Touma 
et al. 2008). Stress reactivity was determined by 
the stress reactivity test (SRT) described below. 
Within each breeding line, two independent sub-
lines, A and B, exist. These sub-lines were never 
interbred and serve as a replication of the breeding 
protocol conducted in parallel (Touma et al., 2008). 
The mice of each group comprised of mice from 
both sub-line. Two weeks prior to the onset of 
behavioral testing all animals were single housed 
under standard laboratory conditions in transparent 
polycarbonate cages (standard macrolon cages type 
II, 38  22  15 cm) with food and water available 
ad libitum. Testing and housing rooms were 
maintained on a 12:12h light-dark cycle with a 
constant temperature and humidity of 22  1 oC 
and 55  10 %, respectively. 
The mice used in the hippocampal 
spectroscopy study originated from the ninth 
breeding generation of the SR mouse model 
(N = 12 per breeding line). The mice used in the 
behavioral tests, hippocampal volume 
measurement, hippocampal activity measurement 
and PFC spectroscopy were derived from the 
twelfth breeding generation (N = 16 per breeding 
line). The mice used for the screening of the 
hippocampal proteome originated from the 
fourteenth breeding generation (N = 4 per breeding 
line). 
  All behavioral tests and hormone 
measurements were conducted during the first 
hours of the light phase when the animals were still 
relatively active and corticosterone levels are at 
their circadian trough. Magnetic resonance imaging 
(MRI) was conducted throughout the light phase. 
The time of day of scanning and behavioral testing 
was counterbalanced across the groups. The 
presented work complies with current regulations 
covering animal experimentation in Germany and 
the EU (European Communities Council Directive 
86/609/EEC). All experiments were announced to 
the appropriate local authority and were approved 
by the ‘Animal Welfare Officer’ of the Max Planck 
Institute of Psychiatry. 
 
 
DETERMINATION OF HPA AXIS 
REACTIVITY 
Stress Reactivity Test (SRT) 
All mice used in these experiments underwent the 
SRT at the age of approximately eight weeks. The 
is comprised of an initial blood sample collected 
from a small incision in the ventral tail vessel, 
followed by a 15-min restraint stressor and finally 
a reaction blood sample, collected from a second 
incision in the ventral tail vessel immediately after 
the period of restraint (for details see (Touma et al., 
2008)). Corticosterone levels in the plasma were 
analyzed as described below.  
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Plasma Corticosterone Measurements 
A radioimmunoassay (RIA) kit (MP Biomedicals, 
Solon, Ohio, USA) was used with a slight 
modification to the manufacturer’s instructions to 
determine corticosterone levels in the plasma 
samples (for details see (Touma et al., 2008)). 
From the initial sample, 10 l of plasma were 
diluted 1:13.5, and for the reaction sample, 10 l of 
plasma were diluted 1:100. The difference in 
dilution was used to ensure that the corticosterone 
concentrations of the samples were within the 
linear part of the standard curve. Inter- and intra-
assay coefficients of variation were both below 
10 %. 
 
 
MAGNETIC RESONANCE MEASUREMENTS 
Apparatus  
At the age of 20 weeks, each animal underwent a 
proton magnetic resonance spectroscopy (1H-MRS) 
scan and/or manganese enhanced magnetic 
resonance imaging (MEMRI). Mice were 
anesthetized with isoflurane (DeltaSelect, 
Germany), fixed and further kept under inhalation 
anesthesia with an isoflurane-oxygen mixture (1.5 
– 1.9 vol % with an oxygen flow of 1.2 – 1.4 
l/min). Head movements were prevented by fixing 
the frontal teeth with a surgical fiber. Body 
temperature was monitored with a rectal 
thermometer (Thermalert TH-5, Physitemp 
Instruments, USA) and kept between 34 – 36 °C 
using a custom build heating pad with warm water 
circulation. Pulse rate was continuously monitored 
by a plethysmographic pulse oxymeter (Nonin 
8600V, Nonin Medical Inc., USA). All MR 
experiments were acquired on a 7 T Avance 
Biospec 70/30 scanner (BRUKER, Germany) using 
a saddle-shaped receive only coil.  
 
Proton Magnetic Resonance Spectroscopy 
Measurements 
Adjustment of the magnetic resonance (MR) 
system and acquisition of localizer images for 
definition of the 3D brain volume and for 
positioning the spectroscopic volume of interest 
was performed with a 2D relaxation enhanced 
(RARE) sequence (TR = 5000 ms, TE = 11.9 ms, 
Rare factor 6, TEeff = 38.8 ms, spatial resolution: 
0.133 x 0.133 x 0.5 mm3).  
For 1H-MRS, a PRESS sequence (TR = 
5000 ms, TE = 17 ms, 256 averages, bandwidth 5 
kHz, 2 K time domain points) with automated 
shimming and manual adjustment of water 
suppression using three chemical shift selective 
(CHESS) pulses was employed. Each spectrum 
was acquired in 21:20 minutes. The acquired 
spectra were analyzed by using LCModel 6.1-4 
with a set of metabolite reference spectra acquired 
under identical experimental conditions. The 
following metabolites were used for spectral 
fitting: Creatine (Cre), γ-aminobutyric acid, 
glucose, glutamate, 
glutamineglycerophosphocholine, phosphocholine, 
myo-inositol, lactate, N-acetylaspartate (NAA), N-
acetyl-aspartylglutamate (NAAG), 
phosphocreatine, scyllo-inositol and taurine, along 
with macromolecules and lipids. The fit was 
performed over a spectral range of 1.0 – 4.2 parts 
per million (ppm). To be included into the analysis, 
the respective metabolites needed a signal-to-noise 
(S/N) ratio in the left or right hippocampus smaller 
or equal to eight and a spectral fitting with a 
standard deviation smaller than 18%. For the PFC 
only spectra with a S/N-ratio smaller than or equal 
to four and a spectral fitting with a standard 
deviation smaller than 18% where included. Due to 
these criteria, three out of 33 spectra had to be 
excluded from the analysis of the left 
hippocampus, and nine out of 33 spectra from the 
analysis of the right hippocampus. For the analysis 
of the PFC, 16 out of 46 spectra had to be excluded 
due to the criteria specified above. For the 
hippocampal spectroscopic volumes, we found a 
full-with-at-half-maximum (FWHM) of 
 0.049 ± 0.003 ppm for the right hippocampus and 
 0.048 ± 0.002 ppm for the left hippocampus 
(mean ± standard error of the mean (SEM)). For 
the PFC, we found a FWHM of  0.058 ± 0.004 
ppm. Metabolic concentrations are conservatively 
presented relative to Cre as an internal standard. 
Cre concentration are given in institutional units 
(i.u.) referenced aginst the unsupressed water 
signal from the spectroscopic volume.  
 
Localization of the Volumes of Interest 
The spectroscopic volume of interest for the dorsal 
hippocampi included mainly dorsal CA1 region 
and parts of the CA2 and CA3 regions and the 
dentate gyrus, reaching from approximately 
Bregma -1.3 mm to Bregma -2.8 mm according to 
the mouse brain atlas (Franklin and Paxinos, 1997). 
The spectroscopic volume was 5.625 l (see Fig. 
1a). Bilateral measurements of the hippocampus 
were performed. 
The volume of interest for the PFC 
included mainly the prelimbic and infralimbic 
cortex and parts of the cingulate cortex, reaching 
from approximatly Bregma +2.3 mm to Bregma 
+1.3 mm according to the mouse brain atlas 
(Franklin and Paxinos, 1997). Here the 
spectroscopic volume was 3.00 l (see Fig. 4a). 
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Manganese Enhanced Magnetic Resonance 
Imaging Measurements 
Animals were injected intraperitoneally (i.p) with a 
50 mM manganese chloride (MnCl2*4H20, Sigma, 
Steinheim, Germany) solution in 0.9% NaCl (pH 
7). The injection protocol was based on the 
fractionated application scheme proposed by 
Gruenecker and colleagues. A total concentration 
of 180 mg/kg was injected in three fractionated 
doses of 60 mg/kg MnCl2 with an inter-injection 
interval of 48 h.  
Mice were scanned 24 hrs after the last 
injection. T1-weighted (T1w) brain images were 
acquired using a 3D gradient echo pulse sequence 
(TR = 50 ms, TE = 3.2 ms, matrix 
size = 128×106×106, zero filled to 128×128×128, 
field of view (FOV) = 16×16×18 mm3, number of 
averages = 10, resulting in a spatial resolution of 
125×125×140.6 µm3 with a total measurement 
duration of 90 min). Additionally, T2-weighted 
(T2w) images were obtained using a RARE 
enhanced pulse sequence (TR = 1000 ms, TE = 10 
ms, matrix size = 128×112×112 zero filled to 
128×128×128, FOV = 16×16×18 mm3, number of 
averages = 2, Rare factor = 16, TEeff = 78.6 ms, 
resulting in a resolution of 125×125×140.6 µm3, 
with a measuring time of around 30 min). T1w- 
and T2w-images were acquired using identical 
image orientation and geometry. Total 
measurement time was around two hours per 
animal.  
 
Magnetic Resonance Imaging Data Processing 
Images were reconstructed using Paravision 
software (Bruker BioSpin, Ettlingen, Germany) 
and transferred to standard ANALYZE format. 
Further post-processing was performed using 
SPM2 (www.fil.ion.ucl.ac.uk/spm). T1w- and 
T2w-images were first co-registered using affine 
transformations. Images were bias corrected to 
remove intensity gradients introduced by geometry 
of the surface coil. A representative T1w- and 
T2w-image, respectively, of one animal was 
selected that served as a first template for the 
generation of a customized second generator 
template.  
For both T1w- and T2w-images, bias 
corrected images of all mice were normalized to 
the single animal template of the respective 
contrast. A group template was then produced 
based on an average of all normalized images of 
the first normalization step. Bias corrected raw 
images of all individual animals were then 
normalized to the group template.  
For improved normalization of T1w-
images, independent of extra-brain tissue as well as 
signal hyperintensity of large vessels typically 
found in T1w-images, a brain extraction step was 
performed first. This was based on normalized 
T2w-images. Due to the better contrast between 
parenchyma and other tissue types and no signal 
hyperintensity of large vessels compared to T1w-
images, a brain extraction step could be performed 
as follows: A binary mask defining the intracranial 
vault without large vessels (total brain) was defined 
(MRIcro, 
www.sph.sc.edu/comd/rorden/mricro.html) on the 
T2w-group template, and transformed to native 
(co-registered) space of each individual animal (by 
inverted spatial normalization). Brain extracted 
images of the co-registered and bias-corrected 
T1w-images were then used for the normalization 
steps of T1w-images. 
Regions of interest (ROIs) were defined 
on the T1w group template for selected structures, 
based on the mouse anatomical atlas (Franklin and 
Paxinos, 1997). As ROIs we defined the 
hippocampus, the prefrontal cortex and the 
ventricles. The extracted total brain volume, 
excluding ventricles, served as an individual 
reference. Binary ROI masks were back-
transformed into native space as described for the 
total brain. Eventually, volume and intensity 
measurements of each ROI were performed on the 
bias-corrected raw T1w-images of each animal 
using in-house written software in IDL 
(www.creaso.com) and normalized to the total 
brain volume and intensity respectively.  
 
 
BEHAVIORAL TESTS 
Y-Maze Test 
The mice were tested in a Y-maze test at the age of 
approximately 24 weeks. to assess hippocampus 
dependent spatial memory (Dellu et al., 2000). The 
details of the test are described elsewhere 
(Knapman et al., 2009). Briefly, the apparatus used 
for this test was Y-shaped and consists of three 
arms bearing a different symbol on the walls. 
During the acquisition phase, the animal was 
allowed to explore two of the arms for ten min. 
After an inter-trial interval of 30 min, where the 
mouse was returned to its home cage, the mouse 
was placed back in the maze for five minutes, this 
time with the opportunity to explore all three arms. 
The animals’ movements were tracked using ANY-
maze software (ANY-maze, Stoelting Co., IL, 
USA). If the animal spent significantly more time 
in the novel arm compared to the mean of the 
familiar arms, it was assumed to have remembered 
the arms it had previously been allowed to explore. 
 
 4
 5
Reversal Learning Test 
In order to test PFC function, the mice were tested 
in a reversal learning test at the age of 
approximately 18 weeks. Briefly, mice were placed 
in a T-maze with an escape tunnel at the end of one 
of the goal arms leading to the home cage. The 
mice were tested with an inter-trial interval of 
approximately 5 min until they reached the 
learning criterion of eight out of ten correct trials. 
The mice were retested 24 hrs later to see if the 
groups differed in memory retention. On the third 
day, i.e. 24 hrs after the retention trial, the goal arm 
with the escape tunnel was moved to the opposite 
arm and the mouse had to learn the new position of 
the arm. For detailes see (Knapman et al., in 
presss). In this paradigm 12 animals per line were 
tested. If an animal failed to reach the learning 
criterion by 30 trials or needed more trials to reach 
the learning criterion on the second day (the 
retrieval phase) it was excluded from the analysis 
at all stages of the test. The final number of 
animals (N) for each group is presented along with 
the outcome of statistical analysis in the results 
section.  
 
 
PROTEOMICS 
Sample Preparation 
At the age of approximately 18 weeks, animals 
were briefly anesthetized with isoflurane and then 
rapidly decapitated. The brain was removed from 
the skull and the hippocampus was subsequently 
bilaterally dissected. The hippocampal tissue was 
then individually homogenized in 1.5 ml eppendorf 
tubes with glass spheres (Sample Grinding Kit, GE 
Healthcare) in 100 μl of so-called IEF buffer (7 M 
urea, 2M thiourea, 4% CHAPS, 2% ASB-14 and 
70 mM DTT buffer) (for details see (Martins-de-
Souza et al., 2007)). Samples were centrifuged at 
17500 rcf for 10 min in order to separate the 
dissolved proteins from the spheres and lipids. The 
dissolved protein samples were individually 
transferred to fresh tubes, and 1 μl of protease 
inhibitor was added to the samples to inhibit 
protein degradation. Samples were mixed and 
stored at -80 ºC until further analysis.  
 
Two–Dimensional Gel Electrophoresis 
The individual hippocampal proteome of four HR 
and four LR mice were compared using two-
dimensional gel electrophoresis (2-DE). The 
methods are described in detail elsewhere 
(Martins-de-Souza et al., 2009). Briefly, 650 μg of 
protein from HR or LR mouse hippocampus were 
applied to IPG gel strips with a nonlinear 
separation range of pH 3-10 prior to the second 
dimension in 12.5 % T (T = Total acrylamide-
bisacrylamide monomer concentration) acrylamide 
gels that were stained using a modified colloidal 
coomassie blue protocol. 
 
 
Determination of Protein Expression Differences 
and Protein Identification by Peptide Mass 
Fingerprinting 
2-DE gel images were used for spot detection and 
pI/MW (isoelectric point/molecular weight) 
calibration using the PDQuest software (Bio-Rad, 
Hercules, CA, USA). One gel from a HR mouse 
could not be scanned due to the gel being 
excessively fragmentized, leaving a total of seven 
2-DE profiles that were analyzed (4 LR mice and 3 
HR mice). Corresponding spots were matched for 
all 2-DE profiles. Five protein spots that differed 
significantly between HR and LR mice were 
excised for mass spectrometry (MS) identification. 
Protein identification by peptide mass 
fingerprinting was done as previously described 
(Martins-de-Souza et al., 2009). 
 
 
STATISTICS 
The data was mainly analyzed using non-
parametric statistics as a normal distribution and 
variance homogeneity of the data could not always 
be assumed. The Kruskal-Wallis H-test (KWH-
test) was used to compare more than two 
independent samples. Post-hoc tests and group 
comparisons of two independent groups were 
performed using the Mann Whitney U-test (MWU-
test), apart from proteomics data that was analyzed 
using the t-test. Sequential Bonferroni correction 
was applied to correct for multiple testing, when 
appropriate. In order to compare two dependent 
samples the Wilcoxon test (W-test) was applied. 
The statistical analysis was performed using SPSS 
software (SPSS Inc, Chicago, IL, USA). Two tailed 
p-values were reported in all cases and statistical 
significance was set to p<0.05. P-values between 
0.05 and 0.1 were reported as trends.  
 
 
RESULTS 
STRESS REACTIVITY TEST 
The differences in initial corticosterone levels and 
restraint stress-induced corticosterone increase 
were highly significant between the three breeding 
lines (HR>IR>LR) in all groups of experimental 
animals i.e. the animals from the ninth, twelfth and 
fourteenth breeding generation in both initial  
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Fig. 1: Localization and volume of region of interest for hippocampal spectroscopic measurements (a) 
and N-acetylaspartate (NAA) levels normalized to Creatin (Cre) in the right (b) and left (c) 
hippocampus of mice selectively bred for high (HR), intermediate (IR) and low (LR) stress reactivity. 
Data are given as box plots showing medians (lines in the boxes), 25% and 75% percentiles (boxes). 
The 10% percentile and 90% percentile are indicated by the whiskers. Data was statistically analyzed 
using the KWH-test followed by post-hoc MWU-tests where appropriate (Bonferroni corrected 
p<0.05*, p<0.01**). 
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corticosterone plasma levels and stress induced 
increase in plasma corticosterone levels. See 
supplementary material for details.  
 
 
MAGNETIC RESONANCE MEASUREMENTS 
Hippocampal Spectroscopy 
The three lines of mice significantly differed in 
their NAA/Cre levels in the right dorsal 
hippocampus, with HR mice demonstrating a 
reduced level compared to both IR and LR mice 
(KWH-test: HR: N = 9, IR: N = 7, LR: N = 9, 
H = 12.4, df = 2, p = 0.002; post-hoc MWU-tests: 
U = 4-27, HR vs. LR: p = 0.006; HR vs. IR: 
p = 0.008; IR vs. LR: p = 0.634; Fig. 1b). 
However, the NAA/Cre level in the left dorsal 
hippocampus did not significantly differ between 
the lines (KWH-test: HR: N = 11, IR: N = 8, LR: 
N = 10, H = 0.1, df = 2, p = 0.934; Fig. 1c). The 
levels of Cre furthermore did not differ between 
the three lines in the right (HR: 32400 ± 1268 i.u., 
IR: 31833 ± 1252  i.u, LR: 31089 ± 2711  i.u; 
KWH-test: HR: N = 9, IR: N = 7, LR: N = 9, 
H = 0.9, df = 2; p = 0.640) or left hippocampus 
( 28709 ± 1126 i.u, IR: 29256 ± 1586 i.u, 
LR: 33840 ± 3659 i.u; KWH-test: HR: N = 11, IR: 
N = 8, LR: N = 10, H = 0.8, df = 2, p = 0.682)  
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Hippocampal Signal Intensity and Volume 
There was a significant difference between the 
three lines in the T1w-signal intensity due to 
manganese accumulation  
in the hippocampus relative to the whole brain 
intensity. HR mice showed a lower signal intensity 
than LR mice and LR mice had a higher signal 
intensity than IR mice, this differences however 
only remained a strong trend values after 
Bonferroni correction (KWH-test: HR: N = 14, IR: 
N = 15, LR: N = 15, H = 6.8, df = 2, p<0.034; post-
hoc MWU-tests: U = 55-90, HR vs. LR: p = 0.058; 
HR vs. IR: p = 0.533; IR vs. LR: p0.078; Fig. 2). 
The hippocampal volume however did not differ 
between the three lines (KWH-test: HR: N = 14, 
IR: N = 15, LR: N = 15, H = 0.1, df = 2, p = 0.700; 
Fig. 3).  
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Fig. 3: Hippocampal volume relative to brain 
volume of mice selectively bred for high (HR), 
intermediate (IR) and low (LR) stress reactivity. 
Data are given as box plots showing medians 
(lines in the boxes), 25% and 75% percentiles 
(boxes). The 10% percentile and 90% percentile 
are indicated by the whiskers. Data was 
statistically analyzed using the KWH-test 
followed by post-hoc MWU-tests where 
appropriate.
 
 
Prefrontal Cortex Spectroscopy 
The three mouse lines significantly differed in their 
NAA/Cre levels in the PFC, with the HR mice 
displaying significantly lower levels than the LR 
mice. Furthermore, the LR mice had higher 
NAA/Cre levels than IR mice, but this difference 
only reached statistical trend values after 
Bonferroni correction (KWH-test: HR: N = 12, IR: 
N = 11, LR: N = 11, H = 11.4, df = 2, p = 0.003; 
post-hoc MWU-tests: U = 55-90, HR vs. LR: 
p = 0.003; HR vs. IR: p = 0.104; IR vs. LR: 
p = 0.056; Fig. 4). 
Fig.2: Relative signal intensity of the 
hippocampus of mice selectively bred for high 
(HR), intermediate (IR) and low (LR) stress 
reactivity. Data are given as box plots showing 
medians (lines in the boxes), 25% and 75% 
percentiles (boxes). The 10% percentile and 90% 
percentile are indicated by the whiskers. Data was 
statistically analyzed using the KWH-test 
followed by post-hoc MWU-tests where 
appropriate (Bonferroni corrected p<0.05*) 
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Fig. 4: Localization and volume of region of interest for prefrontalcortex spectroscopic 
measurements (a) and N-acetylaspartate (NAA) levels normalized to Creatin (Cre) in the 
prefrontal cortex of mice selectively bred for high (HR), intermediate (IR) and low (LR) stress 
reactivity. Data are given as box plots showing medians (lines in the boxes), 25% and 75% 
percentiles (boxes). The 10% percentile and 90% percentile are indicated by the whiskers. Data 
was statistically analyzed using the KWH-test followed by post-hoc MWU-tests where 
appropriate (Bonferroni corrected p<0.01**, p<0.1T). 
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Prefrontal Cortex Signal Intensity 
In contrast to the spectroscopy results the three 
lines did not differ in T1w-signal intensity of the 
cingulate cortex 1 and 2 (HR: 2.09 ± 0.09, 
IR: 2.08 ± 0.03, LR: 2.15 ± 0.04, KWH-test: HR: 
N = 14, IR: N = 15, LR: N = 15, H = 3.6, df = 2, 
p = 0.161), the infralimbic cortex (HR: 1.91 ± 0.03, 
IR: 1.95 ± 0.03, LR: 2.00 ± 0.02, KWH-test: HR: 
N = 14, IR: N = 15, LR: N = 15, H = 2.1, df = 2, 
p = 0.348) or the prelimbic cortex 
(HR: 2.09 ± 0.04, IR: 1.97 ± 0.03, LR: 2.02 ± 0.03, 
KWH-test: HR: N = 14, IR: N = 15, LR: N = 15, 
H = 3.8, df = 2, p = 0.147).  
 
Volumes of the Ventricles 
Interestingly, LR mice were revealed to have 
significantly larger relative lateral ventricle volume 
than HR and IR mice (KWH-test: HR: N = 14, IR: 
N = 15, LR: N = 15, H = 25.7, df = 2, p<0.001; 
post-hoc MWU-tests: U = 10-125, HR vs. LR: 
p<0.001; HR vs. IR: p = 0.533; IR vs. LR: 
p<0.001; Fig. 5) as well as a larger relative volume 
of the third ventricle in comparison to IR mice 
(HR: 6.8E-6 ± 4.7E-7 mm3, IR: 5.8E-6 ± 2.4E-
7 mm3, LR: 8.1E-6 ± 2.4E-7 mm3, KWH-test: HR: 
N = 14, IR: N = 15, LR: N = 15, H = 17.4, df = 2, 
p<0.001; post-hoc MWU-tests: U = 5-74, HR vs. 
LR: p = 0.092; HR vs. IR: p = 0.186; IR vs. LR: 
p<0.001). 
 
HR IR LR
R
el
at
iv
e 
vo
lu
m
e 
0.000
0.005
0.010
0.015
0.020 ******
***
 
 
 
 
 
 
 
 
 
 
 
 
 
Whole Brain Measures 
The intracranial volume did not significantly differ 
between the three lines (HR: 537.1 ± 5.3 mm3, 
IR: 537.1 ± 4.7 mm3, LR: 532.3 ± 7.07 mm3, 
KWH-test: HR: N = 14, IR: N = 15, LR: N = 15, 
H = 0.1, df = 2, p = 0.936). Despite the differences 
in lateral ventricle volume, the total volume of the 
brain (excluding the ventricles) did not differ 
between the three lines (HR: 5237.7 ± 5.7 mm3, 
IR: 532 ± 4.7 mm3, LR: 521.7 ± 6.9 mm3, KWH-
test: HR: N = 14, IR: N = 15, LR: N = 15, H = 1.2, 
df = 2, p = 0.554). The mean T1w signal intensity 
of the whole, as a measure of unspecific 
accumulataion of manganese, did not differ 
between the three lines (HR: 55.7 ± 3.1, 
IR: 50.1 ± 3.5, LR: 50.4 ± 2.0, KWH-test: HR: 
N = 14, IR: N = 15, LR: N = 15, H = 3.0, df = 2, 
p = 0.225). 
 
 
BEHAVIORAL TESTS 
Y-Maze Test 
HR mice displayed an inferior performance in the 
Y-maze spatial learning test compared to IR and 
LR mice. Both LR and IR mice spent significantly 
more time exploring the novel arm than the 
familiar arms after a 30-min inter-trial-interval, 
demonstrating a recognition of the previously 
explored arms (W-test: IR: N = 12, Z = -2.19, 
p = 0.034; LR: N = 15, Z = -3.35, p = 0.001; Fig. 
6). HR mice, however only tended to prefer the 
novel arm over the familiar one (W-test: N = 12, 
Z = -1.65, p = 0.099; Fig. 6). This indicates that the 
HR mice show deficits in this task.   
 
Reversal Learning Test 
Mice from the three breeding lines did not 
significantly differ in their acquisition of the task 
(KWH-test: HR: N = 11, IR: N = 11, LR: N = 8, 
H = 0.8, df = 2, p = 0.657; Fig. 7), nor did they 
differ in their retention of the task on the 
subsequent day (KWH-test: HR: N = 11, IR: 
N = 11, LR: N = 8,  H = 3.9, df = 2, p = 0.140; Fig. 
7). However, in the reversal phase of the test, HR 
mice needed significantly more trials to reach the 
learning criterion than LR mice (KWH-test: HR: 
N = 11, IR: N = 11, LR: N = 8, H = 7.0, df = 2, 
p = 0.025; post-hoc MWU-tests: U = 14-37, HR vs. 
LR: p = 0.027; HR vs. IR: p = 0.133; IR vs. LR: 
p = 0.258; Fig. 7). 
Fig. 5: Lateral ventricle volume of mice 
selectively bred for high (HR), intermediate (IR) 
and low (LR) stress reactivity. Data are given as 
box plots showing medians (lines in the boxes), 
25% and 75% percentiles (boxes). The 10% 
percentile and 90% percentile are indicated by the 
whiskers. Data was statistically analyzed using the 
KWH-test followed by post-hoc MWU-tests 
where appropriate (p<0.001***). 
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Fig. 6: Y-maze spatial learning test. Percent time spent exploring a novel arm versus the mean
of two familiar arms of mice selectively bred for high (HR), intermediate (IR), and low (LR
stress reactivity, respectively. Data are depicted as box plots showing medians (lines in th
boxes), 25% and 75% percentiles (boxes). The 10% percentile and 90% percentile ar
indicated by the whiskers. Data was statistically analyzed using the W-test (p<0.05*, p<0.1T).
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Fig. 7: Reversal learning test in mice selectively bred for high (HR), intermediate (IR), and 
low (LR) stress reactivity. The number of trials necessary to reach the learning criterion of 
8/10 correct trials for each stage of the test, acquisition, retrieval and reversal, are given as box 
plots showing medians (lines in the boxes), 25% and 75% percentiles (boxes). The 10% 
percentile and 90% percentile are indicated by the whiskers. Each phase of the test was 
statistically analyzed separately using the KWH-test followed (results given above the line 
encompassing the perimeter of all three box plots) by post-hoc MWU-tests (results given 
above the line connecting the middle of the box plots being compared) where appropriate 
 
Protein name 
 
 
Biological Process 
 
 
MW 
 
 
pI 
 
 
Regulation 
in HR 
 
Fold 
Change 
 
MASCOT 
Score 
 
ID 
Peptides 
 
Coverage 
(%) 
Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2 Cell communication; Signal 
transduction 38048 5.6 ↑ 3.50 181 19 59 
Pyruvate dehydrogenase E1 
component subunit beta, mitochondrial 
Metabolism; Energy pathways 39254 6.41 ↑ 3.50 64 9 29 
Cofilin-1 
Cell growth and/or 
maintenance 18776 8.22 ↓ -2.48 183 10 65 
Glutamate dehydrogenase 1, 
mitochondrial 
Metabolism; Energy pathways 61640 8.05 ↑ 18.41 242 26 44 
Pyruvate kinase isozymes M1/M2 
Metabolism; Energy pathways 58378 7.18 ↑ 4.02 188 18 38 
Aconitate hydratase, mitochondrial 
Metabolism; Energy pathways 86151 8.08 ↑ 5.09 278 25 37 
 
 
 
 
 
 
Tab. 1: Proteins differentially regulated in the hippocampus of high (HR) or low (LR) stress reactive mice. All proteins listed differ significantly in expression 
between HR and LR mice (t-test) with p<0.05. The arrows indicate an up (↑) or down (↓) regulation in HR mice in comparison to LR mice. The moleuclar weight 
(MW) and isoelectric point (pI) values were determined using LaGrange regression.  
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ive protein spots were found to differ between LR 
HR mice. For a represenative gel please see 
pplementary Fig. 1. All spots were successfully 
entified by MALDI-TOF/TOF. One of these 
s contained two distinct proteins leading to a 
otal of six identified proteins. These proteins are: 
filin-1 (p = 0.003, fold change LR × HR: -2.48), 
utamate dehygrogenase 1 (p<0.001, fold change 
 × HR: 18.41), pyruvate kinase isozymes 
1/M2 (p = 0.028, fold change LR × HR: 4.02), 
tate hydratase (p = 0.002, fold change LR × 
: 5.09), guanine nucleotide-binding protein 
I)G(S)/G(T) subunit beta-2/ pyruvate 
drogenase E1 subunit beta (p = 0.027, fold 
LR × HR: 6.4). Their biological 
gnificance and molecular functions were 
ained using the Human Protein Reference 
ase (HPRD –http://www.hprd.org). The 
ority of these proteins were involved in 
m/energy pathways. The results are 
ummarized in table 1.  
ISCUSSION 
sing behavioral tests, MEMRI, 1H-MRS, and 
ics we have here investigated the effects of 
creased stress reactivity on cognitive function, 
euronal activity, integrity and hippocampal 
otein expression in a mouse model selectively 
red for extremes in stress reactivity. 
The HR mice are unique in the aspect that 
hey are genetically predisposed to develop an 
creased HPA axis reactivity. Unlike most models 
 depression focusing on a dysrergulated HPA 
he HR mice have not repeatedly been 
jected to a defined experimental stressor, 
ver, they are likely to be subjected to 
ncreased amounts of glucocorticoids in response 
nts such as hadling, cage changing or 
ve encounters with conspecifics. This 
rovides a more natural model of HPA axis 
sregulation in psychiatric diseases. HR mice 
rthermore have an increased circadian trough 
el of corticosterone, which also contributes to 
ncreased glucocorticoid exposure (Touma et al., 
008; Touma et al., 2009).  
As expected, we found a reduction of 
AA/Cre in both the dorsal hippocampus and the 
HR mice (see Fig. 1 & 4). NAA was 
itially believed to reflect neuronal loss (Sager et 
., 1995), but this assumption has been questioned 
d NAA levels were found to be 
ersible (Davie et al., 1994; Hugg et al., 1996; 
alra et al., 1998; Gonul et al., 2006; Block et al., 
2009). This suggests that NAA levels are mo
strongly linked to the functional integrity of th
neurons. Some studies conducted on depresse
patients have reported a reduction in NAA/Cre i
the prefrontal region in comparison to health
controls (Gruber et al., 2003; Gonul et al., 2006) in 
concordance to our findings, whereas other studi
have found no such difference (Coupland et al
2005; Nery et al., 2009). These studies, howeve
did not investigate HPA axis activity in the patien
sample, which may explain some of th
discrepancies between the reported finding
Furthermore, several studies of patients sufferin
from SZ reported decreased NAA/Cre levels in the
hippocampus compared to healthy controls
(Bertolino et al., 1998; Blasi et al., 2004) 
similarity to our findings. 
A close relationship between gluco
metabolism and NAA synthesis has bee
demonstrated in humans (Moreno et al., 2001). I
has also been proposed that low NAA levels coul
reflect mitochondrial dysfunction (Clark, 1998
Signoretti et al., 2001). Together with our findin
of altered protein expression of several
mitochondrial proteins, this may suggest that th
mitochondria of the HR mice could be damaged by
increased glucocorticoid exposure during their lif
Corticosterone has been shown to suppress
adenosine-5'-triphosphate (ATP) production 
mitochondria from hypothalamic cell cultures 
(Fujita et al., 2009) and hippocampal cell cultures
(Brooke et al., 1998). Interestingly, the comparison
of the HR and LR hippocampal proteome revealed
that several proteins involved in energy
metabolism were indeed differentially regulated 
between the lines. This is in accordance with post
mortem studies in patients suffering from MD, S
and bipolar disorder that have reported alterations
in several proteins involved in energy metabolis
(Iwamoto et al., 2005; Beasley et al., 200
Martins-De-Souza et al., 2010). 
Another protein found to be differential
expressed in HR and LR mice was cofilin 1, which
has previously been demonstrated to inhibi
glucocorticoid receptors (Ruegg et al., 2004). The
biological function of an inhibitor of glucocorticoi
receptors would most likely be to regulate the
amount of glucocorticoid receptors that are
activated in order to protect the cells from bein
damaged due to excess glucocorticoids (Rogatsky
et al., 1999; Ruegg et al., 2004; Amaral et al.,
2009). Thus, a decreased expression of cofilin 1 in 
HR mice might lead to an increased susceptibilit
to damage incurred by glucocorticoids, howeve
further experiments would have to be conducted 
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substantiate this theory. Interestingly, cofilin 1 was 
also found to be down-regulated in the PFC of SZ 
brain tissue (Martins-de-Souza et al. 2009a). 
In the context of NAA measurements and 
energy balance, it is important to note that the three 
lines did not differ in their absolute Cre levels, as 
the NAA values were normalized to Cre. Cre is 
known to be involved in maintaining the energy 
balance in the brain and is reported to be 
neuroprotective (Chaturvedi and Beal, 2008). This 
is in accordance with previously published data 
showing that there are no effects of glucocorticoid 
exposure on Cre levels in healthy subjects (Scheel 
et al., 2009). 
The relative T1w-signal intensity in the 
hippocampus,  as assessed by MEMRI, was also 
reduced in HR mice compared to LR mice. 
Manganese enters the cells via voltage-gated 
calcium channels (Simpson et al., 1995). Thus, the 
more active the neuron, the more the calcium 
channels will open and the more manganese will 
accumulate in the cell, leading to increased signal 
intensity. Therefore, it may be assumed that 
reduced T1w image intensity in the hippocampus 
of HR reflects a reduced activity of the 
hippocampal neurons. 
Interestingly, we did not find any decrease 
in the volume of the hippocampus of HR mice, 
which implies that the volumetroc, functional, and 
metabolic markers show different aspects of 
detrimental effects of increased stress reactivity. 
Lower functional activity and reduced NAA levels 
in HR mice may primarily be caused by 
mitochondrial dysfunction, whereas hippocampal 
atrophy due to hypercortisolism is subtle. Clinical 
studies have found contradicting results regarding 
hippocampal volume in MD, with some studies 
indicating that patients suffering from unipolar 
depression have reduced hippocampal volume in 
comparison to healthy controls (Bremner et al., 
2000; Campbell et al., 2004; Kaymak et al., 2009; 
McKinnon et al., 2009) and others reporting no 
such difference (Keller et al., 2008; Bearden et al., 
2009; Kronmuller et al., 2009). 
HR mice exhibited the lowest MEMRI 
signal intensity of the three breeding lines in the 
PFC, however, the intensity of this region was not 
significantly decreased in comparison to IR or LR 
mice. This does not coincide with the findings of 
decreased signal intensity along with decreased 
NAA/Cre levels in the hippocampus, however, the 
two measures need not coincide as they reflect 
different aspect of cellular functions. 
The behavioral measures correspond well 
with the functional alterations of the hippocampus 
and prefrontal cortex. The hippocampus-dependent 
(Sanderson et al., 2009) spatial learning test used 
here, the Y-maze test, demonstrates that the HR 
mice have inferior spatial memory compared to the 
IR and LR mice. This has also been shown in 
previous studies (Knapman et al., 2009) 
Furthermore, the increased amount of trials needed 
by the HR mice to complete the reversal phase of 
the reversal learning test demonstrate that HR mice 
show perseverance, indicative of poor PFC 
function. This is accordance with previously 
published data (Knapman et al., in press-b). The 
results of the behavioral test fit well with the 
decreased amount of NAA/Cre in the prefrontal 
cortex and hippocampus of the HR mice.  
Interestingly, the LR mice were 
serendipitously found to have larger lateral 
ventricles than both IR and HR mice. As LR mice 
perform better than IR and HR mice in cognitive 
tests and have a higher NAA concentration in the 
hippocampus and PFC in comparison to the other 
two breeding lines, it would appear that this 
increase in ventricle size does not lead to a reduced 
functioning of the brain structures in the vicinity of 
the ventricles. A possible positive aspect of 
enlarged ventricles could be that also the 
subventricular zone (SVZ) is enlarged, as it lies 
adjacent to the lateral walls of the lateral ventricles. 
Cells originating in the SVZ migrate to the corpus 
callosum, striatum, and fornix where they 
differentiate into oligodendrocytes (Menn et al., 
2006). The ventricular system has furthermore 
been implicated in transporting nutrients and waste 
(Lowery and Sive, 2009), as well as carrying 
signaling molecules that regulate neurogenesis and 
cell survival (Miyan et al., 2003; Johanson et al., 
2008). It should however be mentioned that most 
studies reporting enlarged ventricles have found 
larger ventricles in patients suffering from 
psychiatric diseases such as SZ (Chua and 
McKenna, 1995; Wright et al., 2000; Shenton et 
al., 2001) and MD (Shima et al., 1984). It is 
therefore important to distinguish between 
pathologically increased ventricles that may be 
causing internal hydrocephalus and ventricles that 
are simply larger without any loss of intracranial 
volume, as is the case of the LR mice. C57/BL-6 
mice are for example generally better at cognitive 
tests than CD-1 mice (Dellu et al., 2000; Gerlai, 
2002) and have larger ventricles (Li et al., 2009; 
Nag et al., 2009) than all three lines of mice 
examined here. 
Taken together the alterations of the 
hippocampus and PFC of HR mice are very similar 
to what is observed in patients suffering from MD 
and SZ. Furthermore, the finding of an altered 
expression of several proteins involved in energy 
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metabolism in HR mice compared to LR mice 
lends support to the hypothesis of mitochondrial 
dysfunction in psychiatric diseases. The HR mice 
could thus be used in future studies probing the 
underlying mechanisms of hippocampal and PFC 
dysfunction in psychiatric diseases and be a 
promising tool in the search for new targets for the 
treatment of MD and SZ.  
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SUPPLEMENTARY MATERIAL  
 
 
 
Fig. 1: Representative 2-dimentional gel indicating the identified spots; Guanine nucleotide binding protein 
subunit beta-2 and Pyruvate dehydrogenase E1 component subunit beta (spot 1), Cofillin 1 (spot 2), 
Glutamate dehydrogenase 1 (spot 3), Puyruvate kinase isozymes M1/M2 (spot 4) and Aconitate hydratase 
(spot 5).   
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plasma corticosterone levels and reaction plasma corticosterone levels (i.e. increase in response to a standardized stressor) in mice selectively bred for high (HR), 
), and low (LR) stress reactivity. Mice are derived from breeding generations (Gen.) nine, twelve and fourteen. Data was statistically analyzed using the KWH-test 
y post-hoc MWU-tests where appropriate (Bonferroni corrected p<0.05*, p<0.01**, p<0.001***, >0.1 = T) 
intermediate (IR
followed b
 
  Initial plasma corticosterone  
levels 
KWH-test Post hoc MWU-test 
 N Mean ± SEM Group Comparison  HR vs. LR HR vs. IR IR vs. LR 
Gen HR/IR/LR HR 
 
IR LR H p 
 
 U  p 
 
 p  p  
9 12/12/12 14.4 ± 2.3 
 
5.5 ± 1.8 2.1 ± 0.6 18 <0.001 *** 3-46 <0.001 *** 0.003 *** 0.143 n.s 
12 16/15/15 10.42 ± 2.4 
 
3.52 ± 1.3 0.92 ± 0.1 18 <0.001 *** 29-75 <0.001 *** 0.078 T 0.002 ** 
14 4/0/4 10.5 ± 3.3 
 
 3.0 ± 1.9    2 0.083 T     
 
  Reaction plasma corticosterone 
levels 
KWH-test Post hoc MWU-test 
 N Mean ± SEM Group Comparison  HR vs. LR HR vs. IR IR vs. LR 
Gen HR/IR/LR HR 
 
IR LR H p 
 
 U  p 
 
 p  p  
 9 12/12/12 327.5 ± 8.4 
 
184.1 ± 6.3 73.3 ± 4.2 
 
31 <0.001 *** 0 <0.001 *** <0.001 *** <0.001 *** 
12 16/15/15 376.2 ± 19.0 
 
183.7 ± 3.7 78.02 ± 9.8 40 <0.001 *** 0 <0.001 *** <0.001 *** <0.001 *** 
14 4/0/4 453.1 ± 35.3 
 
 49.8 ± 8.4    0 0.021 *     
 
Tab. 1: Initial 
 
 
